<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0061">
    <title>44 Vibrio and Related Organisms</title>
    <sect1 id="ch0061s0001">
      <title>44 Vibrio and Related Organisms</title>
      <anchor id="ch0061s000001a0001"/>
      <anchor id="ch0061s000000a0001"/>
      <para role="chapterAuthor"><phrase role="center">WILLIAM A. GLOVER, II, YANN F. BOUCHER, CHRISTINE C. LEE, AND CHERYL L. TARR</phrase>
      </para>
      <sect2 id="ch0061s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0061s000001a0002"/>
        <anchor id="ch0061s000000a0002"/>
        <para id="ch0061s000000p0001">The family<emphasis>Vibrionaceae</emphasis> is presently composed of eleven genera (<emphasis>Aliivibrio, Catenococcus, Echinimonas, Enterovibrio, Grimontia, Paraphotobacterium, Photobacterium, Salinivibrio, Thaumasiovibrio, Veronia</emphasis>, and <emphasis>Vibrio</emphasis>) and well over 110 species with standing in bacterial nomenclature (<link linkend="ch0061s000000li0001">1</link>). <emphasis>Vibrio</emphasis> is the type genus for the family, and <emphasis>Vibrio cholerae</emphasis>, which includes strains that cause pandemic cholera, is the type species (<link linkend="ch0061s000000li0002">2</link>). Species that are routinely isolated from human clinical specimens can be found in three genera, including <emphasis>Vibrio</emphasis> (16 species) as well as <emphasis>Photobacterium</emphasis> and <emphasis>Grimontia</emphasis> (one species each from clinical specimens). Phylogenetic investigations indicate that multiple monophyletic clades (separate or distinct groups in a phylogenetic sense) exist within <emphasis>Vibrio</emphasis>, which has led to the reclassification of some species into different genera.</para>
      </sect2>
      <sect2 id="ch0061s0001s0002">
        <title>DESCRIPTION OF THE VIBRIONACEAE</title>
        <anchor id="ch0061s000001a0003"/>
        <anchor id="ch0061s000000a0003"/>
        <para id="ch0061s000000p0002">The<emphasis>Vibrionaceae</emphasis> found in clinical specimens are Gram-negative, facultatively anaerobic, straight, curved, or comma-shaped rods, 0.5 to 0.8 μm in width and 1.4 to 2.6 μm in length, that are catalase and oxidase positive (except <emphasis>Vibrio metschnikovii</emphasis>) (<link linkend="ch0061s000000li0002">2</link>). Most species are motile by means of sheathed single or multiple polar flagella when grown in liquid media. Strains of some species, such as <emphasis>Vibrio parahaemolyticus</emphasis> and <emphasis>Vibrio alginolyticus</emphasis>, swarm on solid media by production of numerous lateral flagella (<link linkend="ch0061s000000li0002">2</link>, <link linkend="ch0061s000000li0003">3</link>). All <emphasis>Vibrionaceae</emphasis> require Na<subscript>+</subscript> for growth, with the minimal concentration for optimum growth ranging from 0.029 to 4.1% NaCl (<link linkend="ch0061s000000li0002">2</link>). They ferment <phrase role="small">D</phrase>-glucose but rarely produce gas, reduce nitrate to nitrite (except <emphasis>V. metschnikovii</emphasis>), and grow on thiosulfate-citrate-bile salts-sucrose (TCBS) medium (except <emphasis>Grimontia hollisae</emphasis>). The G+C content of their DNA is 38 to 51 mol% (<link linkend="ch0061s000000li0002">2</link>). Utilization of the vibriostatic agent O/129 can be helpful in differentiating vibrios from other Gram-negative rods but is no longer widely used.</para>
        <para id="ch0061s000000p0003">Key properties or characteristics useful in separating clinically significant<emphasis>Vibrionaceae</emphasis> from phylogenetically related or phenotypically similar species are listed in <anchor id="ch0061s000000a0004"/><link linkend="ch0061s000000a0008">Table 1</link>.</para>
      </sect2>
      <sect2 id="ch0061s0001s0003">
        <title>EPIDEMIOLOGY, TRANSMISSION, AND CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0061s000001a0004"/>
        <anchor id="ch0061s000000a0005"/>
        <para id="ch0061s000000p0004">The genera covered in this chapter are ubiquitous in aquatic environments, primarily marine waters. Vibrios such as<emphasis>V. cholerae, V. paracholerae, V. tarriae, V. metoecus</emphasis>, and <emphasis>V. mimicus</emphasis> that require minimal amounts of Na<subscript>+</subscript> for growth can be found in freshwater rivers and lakes as well as estuarine and marine environments (<link linkend="ch0061s000000li0004">4</link>–<link linkend="ch0061s000000li0006">6</link>). <emphasis>Vibrionaceae</emphasis> are commonly isolated from a variety of bivalves and crustaceans, and like other genera found in marine environments, their concentrations peak during the warmer months of the year. In aquatic environments, vibrios can persist in a free-living state or in association with phytoplankton and zooplankton (<link linkend="ch0061s000000li0007">7</link>, <link linkend="ch0061s000000li0008">8</link>). In the environment, vibrios may enter a state referred to as viable but nonculturable (VBNC), in which cells retain basic metabolic processes even though they fail to grow on standard laboratory media (<link linkend="ch0061s000000li0009">9</link>). Among the vibrios, the VBNC state is best known in <emphasis>V. cholerae</emphasis>, but it has been demonstrated in other pathogenic <emphasis>Vibrio</emphasis> species, including <emphasis>V. parahaemolyticus, V. mimicus</emphasis>, and <emphasis>V. vulnificus</emphasis> (<link linkend="ch0061s000000li0010">10</link>). <emphasis>V. cholerae</emphasis> in the VBNC state poses a risk to public health because it can be resuscitated in the human gastrointestinal tract, but detection in water may be unsuccessful if traditional culture methods are used (<link linkend="ch0061s000000li0011">11</link>).</para>
        <para id="ch0061s000000p0005">The<emphasis>Vibrionaceae</emphasis> have been isolated from a wide variety of intestinal and extraintestinal human illnesses. These illnesses include diarrhea, soft tissue disease (cellulitis and necrotizing fasciitis), septicemia, and eye and ear infections (<link linkend="ch0061s000000li0002">2</link>). Preexisting liver disease is a known risk factor for more severe <emphasis>Vibrio</emphasis> infections and has been associated with elevated serum iron levels, which have been reported to play a role in <emphasis>Vibrio</emphasis> pathogenesis (<link linkend="ch0061s000000li0012">12</link>, <link linkend="ch0061s000000li0013">13</link>). In some cases of gastroenteritis and extraintestinal infections, it may be difficult to determine if a positive <emphasis>Vibrio</emphasis> detection represents true infection or merely colonization, because of its widespread occurrence in marine and estuarine waters. Ten <emphasis>Vibrio</emphasis> species and one species each of <emphasis>Photobacterium</emphasis> and <emphasis>Grimontia</emphasis> occur in clinical specimens and are listed in <anchor id="ch0061s000000a0006"/><link linkend="ch0061s000000a0021">Table 2</link> along with their historical phenotypic results and percentages. Three new species closely related to <emphasis>V. cholerae</emphasis> that are difficult to distinguish by phenotypic methods have recently been associated with clinical specimens and are described below. Additional new species also include <emphasis>V. cidicii</emphasis> (<link linkend="ch0061s000000li0014">14</link>), <emphasis>V. injensis</emphasis> (<link linkend="ch0061s000000li0015">15</link>), and <emphasis>V. navarrensis</emphasis> (<link linkend="ch0061s000000li0016">16</link>). Extraintestinal <emphasis>Vibrio</emphasis> infections are frequently associated with traumatic injuries or inapparent exposure to estuarine or marine waters. Primary septicemia may occur after ingestion of raw seafood (oysters) or as a secondary bacteremia subsequent to a wound infection.</para>
        <anchor id="ch0061s000000a0007"/>
        <beginpage pagenum="856"/>
        <table id="ch0061s000000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0061s000000a0008"/><link linkend="ch0061s000000a0004">TABLE 1</link></phrase></emphasis> Properties of the genus <emphasis>Vibrio</emphasis> and its relatives and differentiation from other organisms that are phenotypically similar<superscript><emphasis><anchor id="ch0061s000000a0009"/><link linkend="ch0061s000000a0013">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="7">
            <tbody>
              <row>
                <entry><phrase role="center">Property</phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Vibrio</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Grimontia</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Photobacterium</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Aeromonas</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Plesiomonas</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">Enterobacterales (except <emphasis>Plesiomonas</emphasis>)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Gram stain; morphology</phrase>
                </entry>
                <entry><phrase role="left">Negative; curved rods</phrase>
                </entry>
                <entry><phrase role="left">Negative; curved rods</phrase>
                </entry>
                <entry><phrase role="left">Negative; coccobacilli</phrase>
                </entry>
                <entry><phrase role="left">Negative; straight rods</phrase>
                </entry>
                <entry><phrase role="left">Negative; straight rods</phrase>
                </entry>
                <entry><phrase role="left">Negative; small rods</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Causes or is associated with intestinal or extraintestinal infections in humans</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Oxidase reaction</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Na<superscript>+</superscript> is required for or stimulates growth</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Growth on TCBS agar</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">V<superscript><emphasis><anchor id="ch0061s000000a0010"/><link linkend="ch0061s000000a0014">b</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Sensitivity to vibriostatic compound O/129<superscript><emphasis><anchor id="ch0061s000000a0011"/><link linkend="ch0061s000000a0015">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">+<superscript><emphasis><anchor id="ch0061s000000a0012"/><link linkend="ch0061s000000a0016">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Lipase production</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">D</phrase>-Mannitol fermentation</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0013"/><link linkend="ch0061s000000a0009">a</link></emphasis></superscript>These are general properties of the genera and/or family, but there are exceptions. The properties of <emphasis>Vibrio</emphasis> species apply to the species that occur in human clinical specimens and may not apply to all nonclinical species. +, most strains positive; −, most strains negative; V, variable reaction among the species/strains.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0014"/><link linkend="ch0061s000000a0010">b</link></emphasis></superscript>Strains of <emphasis>G. hollisae</emphasis> typically grow poorly or not at all on TCBS agar; those that grow may have a reduced plating efficiency.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0015"/><link linkend="ch0061s000000a0011">c</link></emphasis></superscript>O/129, 2,4-diamino-6,7-diisopropylpteridine phosphate (commercially available, 150-μg disks).</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0016"/><link linkend="ch0061s000000a0012">d</link></emphasis></superscript>Resistance to O/129 has become common in <emphasis>V. cholerae</emphasis> strains isolated from India and Bangladesh; <emphasis>V. cholerae</emphasis> O139 strains are resistant.</para>
        <para id="ch0061s000000p0006">Due to the favorable growth of<emphasis>Vibrio</emphasis> populations in warm temperatures within aquatic environments, a considerable amount of focus and attention has centered on the impact of climate change on this group of bacteria. Recent reports have described the expansion of <emphasis>Vibrio</emphasis> species into locations previously believed to be unfavorable, particularly in northern regions of the Northern Hemisphere (<link linkend="ch0061s000000li0017">17</link>). Accompanying this reported expansion have been reports of increased human infections as well as outbreaks associated with heat waves (<link linkend="ch0061s000000li0017">17</link>, <link linkend="ch0061s000000li0018">18</link>). Reports suggest that global <emphasis>Vibrio</emphasis> infections will continue their upward trend, further highlighting the importance of this group of bacteria, as well as our ability to recognize, diagnose, identify species, and report cases to national surveillance programs.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0061s0002">
      <title>V. cholerae</title>
      <anchor id="ch0061s000002a0001"/>
      <anchor id="ch0061s000000a0017"/>
      <para id="ch0061s000000p0007"><emphasis>V. cholerae</emphasis> is divided into more than 200 serogroups, of which only <emphasis>V. cholerae</emphasis> serogroups O1 and O139 cause large epidemics and pandemic cholera; however, other serogroups can cause severe dehydrating diarrhea (<link linkend="ch0061s000000li0019">19</link>). Cholera is associated with poor sanitation, and direct contact with contaminated surface water used for drinking, bathing, cooking, and irrigation is a major risk factor (<link linkend="ch0061s000000li0020">20</link>).</para>
    </sect1>
    <sect1 id="ch0061s0003">
      <title>V. cholerae O1</title>
      <anchor id="ch0061s000003a0001"/>
      <anchor id="ch0061s000000a0018"/>
      <para id="ch0061s000000p0008">From September 2019 to September 2020, 16 countries reported outbreaks, with more than 450,000 cases of cholera and over 900 deaths reported to the World Health Organization (WHO) (<link linkend="ch0061s000000li0021">21</link>), with the majority of cases from Yemen (89%). During the past 2 decades, from 2001 through 2021, cholera in Africa has accounted for &gt;50% of the cases worldwide except for two periods in which the Haiti and Yemen outbreaks took place. From 2010 to 2012, an epidemic in Haiti accounted for the majority of cholera cases (<link linkend="ch0061s000000li0022">22</link>). A total of 795,794 cases of infection and 9,411 deaths were reported in Haiti through December 2016, after which the outbreak waned significantly. The epidemic in Haiti has now been surpassed by the cholera outbreak in Yemen. From October 2016 to April 2021, a total of 2,538,677 cases with 3,997 deaths have been reported (<link linkend="ch0061s000000li0023">23</link>).</para>
      <para id="ch0061s000000p0009">A majority of<emphasis>V. cholerae</emphasis> O1 infections are asymptomatic, and these undetected infections may serve as an ongoing reservoir in regions where cholera is endemic (<link linkend="ch0061s000000li0024">24</link>). Severe infections typically result in copious watery diarrhea, with fluid loss reaching 200 ml/kg of body weight/day. If untreated, the patient becomes prostrate with symptoms of severe dehydration, electrolyte imbalance, painful muscle cramps, watery eyes, loss of skin elasticity, and anuria. Dehydration subsequently leads to hypovolemic shock, acidosis, circulatory collapse, and death, even in previously healthy adults (<link linkend="ch0061s000000li0025">25</link>). In the United States, occasional cases of cholera are seen in travelers returning from regions of the world where cholera is endemic. Traditional therapy consists of fluid replacement by oral rehydration and/or intravenous fluids.</para>
      <para id="ch0061s000000p0010">The unique ability of<emphasis>V. cholerae</emphasis> serogroup O1 to cause this fulminant form of diarrhea is due to the presence of virulence cassette regions and pathogenicity islands on the bacterial chromosome. These regions contain a number of key determinants, including the <emphasis>ctxAB</emphasis> genes, encoding cholera enterotoxin, which is responsible for the large excretion of fluids and electrolytes into the lumen, and the TCP gene cluster, which includes <emphasis>tcpA</emphasis>, the gene that encodes the major protein subunit of the toxin-coregulated pilus (responsible for attachment to the gastrointestinal epithelium) (<link linkend="ch0061s000000li0020">20</link>). <emphasis>V. cholerae</emphasis> O1 strains are divided into two serotypes, Inaba and Ogawa (a third serotype, Hikojima, is very rarely isolated), and two biotypes, El Tor and classical. The classical biotype caused the sixth pandemic, while the El Tor biotype, which was first isolated in 1905, is the cause of the ongoing seventh pandemic that began in 1961 (<link linkend="ch0061s000000li0020">20</link>). Recently, new variants of <emphasis>V. cholerae</emphasis> O1 have emerged in Africa and Asia (<link linkend="ch0061s000000li0026">26</link>). These atypical or hybrid El Tor strains may be more virulent than most El Tor strains based upon projected case fatality rates (<link linkend="ch0061s000000li0027">27</link>). Hybrid strains differ from prototypical El Tor isolates in that they share some characteristics with the classical biotype (e.g., an El Tor strain may have the classical <emphasis>ctxB</emphasis> gene on its chromosome) (<link linkend="ch0061s000000li0028">28</link>). These hybrid strains appear to have evolved via lateral gene transfer and recombination events (<link linkend="ch0061s000000li0026">26</link>).</para>
      <anchor id="ch0061s000000a0019"/>
      <beginpage pagenum="857"/>
      <anchor id="ch0061s000000a0020"/>
      <beginpage pagenum="858"/>
      <table id="ch0061s000000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0061s000000a0021"/><link linkend="ch0061s000000a0006">TABLE 2</link></phrase></emphasis> Results of phenotypic tests historically used and properties of 12 <emphasis>Vibrionaceae</emphasis> species that occur in human clinical specimens<superscript><emphasis><anchor id="ch0061s000000a0022"/><link linkend="ch0061s000000a0029">a</link></emphasis>,<emphasis><anchor id="ch0061s000000a0023"/><link linkend="ch0061s000000a0030">b</link></emphasis></superscript>
</title>
        
        <tgroup cols="13">
          <tbody>
            <row>
              <entry><phrase role="center">Test</phrase>
              </entry>
              <entry><phrase role="center">% of strains positive<superscript><emphasis><anchor id="ch0061s000000a0024"/><link linkend="ch0061s000000a0031">c</link></emphasis></superscript></phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="center">
                  <emphasis>V. cholerae</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. mimicus</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. metschnikovii</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0061s000000a0025"/>
                      <link linkend="ch0061s000000a0032">d</link>
                    </emphasis>
                  </superscript>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. cincinnatiensis</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>G. hollisae</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>P. damselae</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. fluvialis</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. furnissii</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. alginolyticus</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. parahaemolyticus</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. vulnificus</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0061s000000a0026"/>
                      <link linkend="ch0061s000000a0033">e</link>
                    </emphasis>
                  </superscript>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>V. harveyi</emphasis>
                </phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Indole (HIB)<superscript><emphasis><anchor id="ch0061s000000a0027"/><link linkend="ch0061s000000a0034">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 98</phrase>
              </entry>
              <entry><phrase role="center"> 20</phrase>
              </entry>
              <entry><phrase role="center">  8</phrase>
              </entry>
              <entry><phrase role="center"> 97</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 13</phrase>
              </entry>
              <entry><phrase role="center"> 11</phrase>
              </entry>
              <entry><phrase role="center"> 85</phrase>
              </entry>
              <entry><phrase role="center"> 98</phrase>
              </entry>
              <entry><phrase role="center"> 97</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">VP<superscript><emphasis><link linkend="ch0061s000000a0034">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center"> 75</phrase>
              </entry>
              <entry><phrase role="center">  9</phrase>
              </entry>
              <entry><phrase role="center"> 96</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Moeller’s</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Arginine<superscript><emphasis><link linkend="ch0061s000000a0034">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 60</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center"> 93</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Lysine<superscript><emphasis><link linkend="ch0061s000000a0034">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 35</phrase>
              </entry>
              <entry><phrase role="center"> 57</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Ornithine<superscript><emphasis><link linkend="ch0061s000000a0034">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center"> 55</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Motility</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 98</phrase>
              </entry>
              <entry><phrase role="center"> 74</phrase>
              </entry>
              <entry><phrase role="center"> 86</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 25</phrase>
              </entry>
              <entry><phrase role="center"> 70</phrase>
              </entry>
              <entry><phrase role="center"> 89</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Gelatin hydrolysis<superscript><emphasis><link linkend="ch0061s000000a0034">f</link></emphasis></superscript> (22°C)</phrase>
              </entry>
              <entry><phrase role="center"> 90</phrase>
              </entry>
              <entry><phrase role="center"> 65</phrase>
              </entry>
              <entry><phrase role="center"> 65</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  6</phrase>
              </entry>
              <entry><phrase role="center"> 85</phrase>
              </entry>
              <entry><phrase role="center"> 86</phrase>
              </entry>
              <entry><phrase role="center"> 90</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center"> 75</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left"><phrase role="small">D</phrase>-Glucose, gas production</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 10</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Acid production from:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left"><phrase role="small">L</phrase>-Arabinose</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 97</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 93</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center"> 80</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Cellobiose</phrase>
              </entry>
              <entry><phrase role="center">  8</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  9</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 30</phrase>
              </entry>
              <entry><phrase role="center"> 11</phrase>
              </entry>
              <entry><phrase role="center">  3</phrase>
              </entry>
              <entry><phrase role="center">  5</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Lactose</phrase>
              </entry>
              <entry><phrase role="center">  7</phrase>
              </entry>
              <entry><phrase role="center"> 21</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  3</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center"> 85</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left"><emphasis>myo</emphasis>-Inositol</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 40</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Salicin</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  9</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  4</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Sucrose</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  5</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center"> 15</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">ONPG</phrase>
              </entry>
              <entry><phrase role="center"> 94</phrase>
              </entry>
              <entry><phrase role="center"> 90</phrase>
              </entry>
              <entry><phrase role="center"> 50</phrase>
              </entry>
              <entry><phrase role="center"> 86</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 40</phrase>
              </entry>
              <entry><phrase role="center"> 35</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  5</phrase>
              </entry>
              <entry><phrase role="center"> 75</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Salt tolerance (growth in nutrient broth with):</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">0% NaCl</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">6% NaCl</phrase>
              </entry>
              <entry><phrase role="center"> 53</phrase>
              </entry>
              <entry><phrase role="center"> 49</phrase>
              </entry>
              <entry><phrase role="center"> 78</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 83</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center"> 96</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 65</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">O/129 susceptibility<superscript><emphasis><anchor id="ch0061s000000a0028"/><link linkend="ch0061s000000a0035">g</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center"> 99</phrase>
              </entry>
              <entry><phrase role="center"> 95</phrase>
              </entry>
              <entry><phrase role="center"> 90</phrase>
              </entry>
              <entry><phrase role="center"> 25</phrase>
              </entry>
              <entry><phrase role="center"> 40</phrase>
              </entry>
              <entry><phrase role="center"> 90</phrase>
              </entry>
              <entry><phrase role="center"> 31</phrase>
              </entry>
              <entry><phrase role="center">  0</phrase>
              </entry>
              <entry><phrase role="center"> 19</phrase>
              </entry>
              <entry><phrase role="center"> 20</phrase>
              </entry>
              <entry><phrase role="center"> 98</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0029"/><link linkend="ch0061s000000a0022">a</link></emphasis></superscript>Abbreviations: HIB, heart infusion broth; VP, Voges-Proskauer; ONPG, <emphasis>o</emphasis>-nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside; NaCl, sodium chloride.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0030"/><link linkend="ch0061s000000a0023">b</link></emphasis></superscript>Newer <emphasis>Vibrio</emphasis> species characterized by molecular phylogenetic methods are not included in this table.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0031"/><link linkend="ch0061s000000a0024">c</link></emphasis></superscript>Percentage of strains positive after 48 h of incubation at 36°C unless indicated. Most positive reactions occur within 24 h.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0032"/><link linkend="ch0061s000000a0025">d</link></emphasis></superscript>This organism is oxidase negative and does not reduce nitrate to nitrite.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0033"/><link linkend="ch0061s000000a0026">e</link></emphasis></superscript>Biogroup 1 strains.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0034"/><link linkend="ch0061s000000a0027">f</link></emphasis></superscript>One percent NaCl is added to specific tests.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0035"/><link linkend="ch0061s000000a0028">g</link></emphasis></superscript>Zone of inhibition present (disk content, 150 μg).</para>
    </sect1>
    <sect1 id="ch0061s0004">
      <title>V. cholerae O139</title>
      <anchor id="ch0061s000004a0001"/>
      <anchor id="ch0061s000000a0036"/>
      <para id="ch0061s000000p0011">In 1992, a new serogroup of<emphasis>V. cholerae</emphasis>, O139 (originally named <emphasis>V. cholerae</emphasis> O139 Bengal), emerged throughout Asia (<link linkend="ch0061s000000li0029">29</link>). This serogroup probably resulted from the lateral transfer of a novel somatic antigen and capsule from an unknown bacterium to an El Tor strain (<link linkend="ch0061s000000li0029">29</link>). O139 and O1 strains carry similar virulence factors, including the <emphasis>ctx</emphasis> and <emphasis>tcpA</emphasis> genes (<link linkend="ch0061s000000li0020">20</link>). Clinical diseases due to O1 and O139 <emphasis>V. cholerae</emphasis> strains are also strikingly similar, except that adults are more frequently affected with O139, since previous infection with <emphasis>V. cholerae</emphasis> O1 is not protective (<link linkend="ch0061s000000li0030">30</link>). In 2002, strains of serogroup O139 reemerged in Bangladesh, causing an estimated 30,000 cases of cholera, primarily in older patients (<link linkend="ch0061s000000li0030">30</link>). To date, no cases of <emphasis>V. cholerae</emphasis> O139 infection have been identified in Africa, although it contributes to the burden of cholera in China (<link linkend="ch0061s000000li0031">31</link>). Three <emphasis>ctx</emphasis>-positive <emphasis>V. cholerae</emphasis> O139 isolates and one <emphasis>ctx</emphasis>-negative <emphasis>V. paracholerae</emphasis> O139 were recently recovered from humans in Bangladesh, including one case of cholera (<link linkend="ch0061s000000li0032">32</link>).</para>
    </sect1>
    <sect1 id="ch0061s0005">
      <title>V. cholerae non-O1, non-O139</title>
      <anchor id="ch0061s000005a0001"/>
      <anchor id="ch0061s000000a0037"/>
      <para id="ch0061s000000p0012">Strains of<emphasis>V. cholerae</emphasis> that do not fall into the O1 or O139 serogroups are designated “non-O1, non-O139” (or simply “non-O1”) and rarely produce cholera toxin. While the diarrhea produced is watery and severe disease is reported, infections are usually milder than typical cholera. Non-O1 strains of <emphasis>V. cholerae</emphasis> that carry cholera toxin genes, such as strains of serogroups O75 and O141, have caused sporadic cases of cholera-like disease in the United States and elsewhere (<link linkend="ch0061s000000li0033">33</link>, <link linkend="ch0061s000000li0034">34</link>). Risk factors for infection appear to be similar to those for other vibrios and include consumption of oysters and other raw or cross-contaminated seafood. In 2011, there was a small outbreak of <emphasis>V. cholerae</emphasis> serogroup O75 infections linked to consumption of raw or lightly cooked oysters from Apalachicola Bay, FL. The diarrheal symptoms were mild, and no cases required rehydration or hospitalization (<link linkend="ch0061s000000li0035">35</link>). In 2018, a small outbreak with cholera-like symptoms (caused by non-O1 <emphasis>V. cholerae</emphasis>) occurred from the consumption of raw herring eggs on Vancouver Island, Canada (<link linkend="ch0061s000000li0036">36</link>).</para>
      <para id="ch0061s000000p0013">Non-O1 vibrios, in contrast to<emphasis>V. cholerae</emphasis> O1, are associated with extraintestinal infections, such as septicemia and epidural brain abscess (<link linkend="ch0061s000000li0012">12</link>, <link linkend="ch0061s000000li0037">37</link>). People at increased risk of developing non-O1 bacteremia include those with liver disease/cirrhosis or hematologic malignancies (<link linkend="ch0061s000000li0012">12</link>). The case fatality rate in these patients ranges from 10 to 65% (<link linkend="ch0061s000000li0012">12</link>, <link linkend="ch0061s000000li0038">38</link>). Strains have also been isolated from ears, wounds, the respiratory tract, and urine (<link linkend="ch0061s000000li0039">39</link>).</para>
    </sect1>
    <sect1 id="ch0061s0006">
      <title>V. mimicus</title>
      <anchor id="ch0061s000006a0001"/>
      <anchor id="ch0061s000000a0038"/>
      <para id="ch0061s000000p0014"><emphasis>V. mimicus</emphasis>, another nonhalophilic species, is phenotypically similar to <emphasis>V. cholerae</emphasis> except that it does not ferment sucrose. Human isolates are uncommon, but it is recovered from patients with diarrhea, in which it may or may not have a causal role, and is usually associated with consumption of uncooked seafood, particularly raw oysters. Very few strains carry the <emphasis>ctxAB</emphasis> genes and can produce cholera-like symptoms. Symptoms generally include abundant watery diarrhea, vomiting, and severe dehydration. Most descriptions of <emphasis>V. mimicus</emphasis> gastroenteritis involve individual case reports, but a large-scale foodborne outbreak of gastroenteritis was reported in Thailand in 2004 (<link linkend="ch0061s000000li0040">40</link>). In that outbreak, over 300 people became ill, and rectal swabs collected from 24 patients all yielded <emphasis>V. mimicus.</emphasis> Presumptive causes of this outbreak included freshwater fish, seafood, and seafood soup. In 2010, a small outbreak in Washington State occurred after consumption of crayfish and was attributed to a <emphasis>V. mimicus</emphasis> strain encoding cholera toxin (<link linkend="ch0061s000000li0041">41</link>).</para>
    </sect1>
    <sect1 id="ch0061s0007">
      <title>V. parahaemolyticus</title>
      <anchor id="ch0061s000007a0001"/>
      <anchor id="ch0061s000000a0039"/>
      <para id="ch0061s000000p0015"><emphasis>V. parahaemolyticus</emphasis> is the leading cause of bacterial foodborne intestinal infections in Asia and is almost invariably associated with the consumption of raw fish or shellfish (<link linkend="ch0061s000000li0042">42</link>). In Japan, 50 to 70% of the cases of foodborne diarrhea are due to <emphasis>V. parahaemolyticus.</emphasis> In the United States, it is the <emphasis>Vibrio</emphasis> species most frequently isolated from clinical specimens and is associated primarily with watery diarrhea but also may be isolated from blood, wounds, or other extraintestinal sites (<link linkend="ch0061s000000li0043">43</link>). Symptoms of <emphasis>V. parahaemolyticus</emphasis>-associated gastroenteritis often include nausea, vomiting, abdominal cramps, low-grade fever, and chills. Fatalities are extremely rare but can occur in cases of severe dehydration. Rehydration is usually the only treatment needed, but antimicrobial therapy may be beneficial in some instances. An outbreak of gastroenteritis involving 22 passengers aboard a cruise ship was linked to consumption of raw Alaskan oysters (<link linkend="ch0061s000000li0044">44</link>). A now widely dispersed clone of <emphasis>V. parahaemolyticus</emphasis>, serotype O3:K6, emerged worldwide in 1997 (<link linkend="ch0061s000000li0045">45</link>). Strains of this serotype caused an unusually high proportion of <emphasis>V. parahaemolyticus</emphasis> foodborne disease outbreaks in Taiwan from 1996 to 1999, which suggests that there is something unusual regarding its ecology, epidemiology, or virulence. Serovariants are strains of other serotypes possessing a genetic and molecular profile identical to the O3:K6 pandemic clone (<link linkend="ch0061s000000li0045">45</link>). Over 20 serovariants have been described (e.g., O4:K68, O1:K25, and O14:KUT), which along with O3:K6 have continued to spread throughout Asia and to the United States, Canada, Mexico, Russia, France, Italy, Brazil, Chile, Peru, and Mozambique (<link linkend="ch0061s000000li0045">45</link>).</para>
    </sect1>
    <sect1 id="ch0061s0008">
      <title>V. vulnificus</title>
      <anchor id="ch0061s000008a0001"/>
      <anchor id="ch0061s000000a0040"/>
      <para id="ch0061s000000p0016"><emphasis>V. vulnificus</emphasis> causes primary septicemia and wound infection and is responsible for more than 90% of deaths due to vibrios in the United States yearly. Primary septicemia has a fatality rate exceeding 50%, even with hospitalization, and occurs predominantly in men over 50 years old (<link linkend="ch0061s000000li0013">13</link>). Patients usually have predisposing conditions, such as liver disease, immunosuppression, increased serum iron, or other chronic diseases (<link linkend="ch0061s000000li0013">13</link>, <link linkend="ch0061s000000li0046">46</link>). CDC data indicate that &gt;95% of patients consumed raw oysters within 7 days of their infection. Patients typically present with a sudden onset of fever and chills, vomiting, diarrhea, and abdominal pain. Secondary skin lesions often appear, progressing to bulla formation and necrosis. Endotoxic shock often occurs and can rapidly lead to death. Both blood cultures and biopsy samples (scrapings) from skin lesions are usually positive. <emphasis>V. vulnificus</emphasis> also causes severe wound infections, usually after trauma and exposure to marine animals or the marine environment (<link linkend="ch0061s000000li0013">13</link>). Wound infections may progress to cellulitis with extensive necrosis (often requiring surgical debridement), myositis, and necrotizing fasciitis that may mimic gas gangrene, as well as to secondary septicemia. The fatality rate for wound infections ranges from 20 to 30%. Three biogroups have now been defined for <emphasis>V. vulnificus</emphasis> (<link linkend="ch0061s000000li0013">13</link>). Most infections in the United States are due to biogroup 1; biogroup 2 has been isolated principally from diseased eels and from one human wound infection. <emphasis>V. vulnificus</emphasis> biogroup 3 was described in 1999 and has been limited to wound and blood-borne disease in Israeli patients exposed to live tilapia fish grown in aquaculture (<link linkend="ch0061s000000li0013">13</link>).</para>
      <anchor id="ch0061s000000a0041"/>
      <beginpage pagenum="859"/>
    </sect1>
    <sect1 id="ch0061s0009">
      <title>V. alginolyticus</title>
      <anchor id="ch0061s000009a0001"/>
      <anchor id="ch0061s000000a0042"/>
      <para id="ch0061s000000p0017"><emphasis>V. alginolyticus</emphasis> is very common in the marine ecosystem and is the second most commonly isolated <emphasis>Vibrio</emphasis> species in the United States. It is most frequently isolated from ear specimens and wound infections following seawater exposure according to data collected through the CDC’s Cholera and Other <emphasis>Vibrio</emphasis> Illness Surveillance system (COVIS). A woman was diagnosed with a <emphasis>V. alginolyticus</emphasis> infection after sea bathing in the British Isles and applying an unsterile seaweed dressing to a preexisting wound (<link linkend="ch0061s000000li0047">47</link>). <emphasis>V. alginolyticus</emphasis> has also been isolated from ocular infections and from infrequent cases of monomicrobial or polymicrobial bacteremia, mostly in immunocompromised people (<link linkend="ch0061s000000li0048">48</link>, <link linkend="ch0061s000000li0049">49</link>). Isolates are occasionally cultured from diarrheal stool (<link linkend="ch0061s000000li0050">50</link>), but there is no evidence that it actually causes diarrhea.</para>
    </sect1>
    <sect1 id="ch0061s0010">
      <title>Photobacterium damselae</title>
      <anchor id="ch0061s000010a0001"/>
      <anchor id="ch0061s000000a0043"/>
      <para id="ch0061s000000p0018"><emphasis>P. damselae</emphasis> (formerly <emphasis>V. damsela</emphasis>) is an aggressive pathogen that causes serious life-threatening illnesses. Fatality rates for <emphasis>P. damselae</emphasis> are unknown, but many reports in the literature describe fatal infections, suggesting a fairly high attributable mortality rate (<link linkend="ch0061s000000li0051">51</link>). Disease syndromes associated with this bacterium include soft tissue infections (cellulitis and necrotizing fasciitis) and bacteremia. Most wound infections develop as indolent processes that progress to more-severe disease within a matter of hours, and vibrios are often not suspected during the initial diagnosis. In addition to antibiotics, medical intervention, including irrigation, fasciotomy, debridement, and sometimes amputation, is often required.</para>
      <para id="ch0061s000000p0019">Typically,<emphasis>P. damselae</emphasis> wound infections occur in fishermen and -women and result from penetrating traumas caused by fish fins, fishhooks, or harpoons (<link linkend="ch0061s000000li0051">51</link>–<link linkend="ch0061s000000li0053">53</link>). More recently, however, other sources of infection/colonization have been reported for this organism. These include a case of cellulitis in a healthy teenage surfer who sustained a laceration to his hand from his surfboard and a urinary tract infection in a pregnant female who had sexual intercourse in the Caribbean Sea 1 week prior to infection (<link linkend="ch0061s000000li0054">54</link>, <link linkend="ch0061s000000li0055">55</link>).</para>
    </sect1>
    <sect1 id="ch0061s0011">
      <title>Vibrio fluvialis and Vibrio furnissii</title>
      <anchor id="ch0061s000011a0001"/>
      <anchor id="ch0061s000000a0044"/>
      <para id="ch0061s000000p0020"><emphasis>V. fluvialis</emphasis> appears to cause sporadic cases of diarrhea worldwide, with severe cases of gastroenteritis sometimes linked to bacteremia (<link linkend="ch0061s000000li0056">56</link>). <emphasis>V. fluvialis</emphasis> was found in 1.1% of patients with diarrhea in Kolkata, India, from 2002 to 2009, but it was the sole pathogen in only 33% of those cases (<link linkend="ch0061s000000li0057">57</link>). Based on published reports, there appears to be small but increasing incidence of <emphasis>V. fluvialis</emphasis> isolates cultured from extraintestinal sites. These include cases of acute soft tissue infections (cellulitis) associated with cerebritis and bacteremia (<link linkend="ch0061s000000li0058">58</link>, <link linkend="ch0061s000000li0059">59</link>). For many of these systemic infections, some of which have poor outcomes, vibrios are not initially suspected as a cause. They are eventually associated with seafood consumption or exposure to seawater. <emphasis>V. furnissii</emphasis> is rarely isolated from human clinical specimens, but when it is recovered, it is usually from fecal specimens of patients with diarrhea (<link linkend="ch0061s000000li0060">60</link>). Its causal role is unproven but deserves investigation. A case of bacteremia caused by <emphasis>V. furnissii</emphasis> following ingestion of seafood has been described (<link linkend="ch0061s000000li0061">61</link>).</para>
    </sect1>
    <sect1 id="ch0061s0012">
      <title>Miscellaneous Vibrios and Vibrio-Like Organisms</title>
      <anchor id="ch0061s000012a0001"/>
      <anchor id="ch0061s000000a0045"/>
      <para id="ch0061s000000p0021"><emphasis>Vibrio harveyi</emphasis> is an important pathogen of marine fish and invertebrate species. Since 2018, the National Reference Laboratory at CDC has confirmed 16 isolates of <emphasis>V. harveyi</emphasis> (author unpublished data). <emphasis>V. harveyi</emphasis> infections remain rare, with published case reports of human infection associated with water wound exposures, including two recent wound infections, one a mixed infection of <emphasis>P. damselae</emphasis> and <emphasis>V. harveyi</emphasis> (<link linkend="ch0061s000000li0062">62</link>, <link linkend="ch0061s000000li0063">63</link>). There is an anecdotal report of two isolates from blood and gallbladder (clinical history was not available) that were retrospectively identified by <emphasis>rpoB</emphasis> sequencing (<link linkend="ch0061s000000li0064">64</link>). <emphasis>G. hollisae</emphasis> (formerly <emphasis>Vibrio hollisae</emphasis>) is a halophilic <emphasis>Vibrio</emphasis>-like species associated primarily with moderate to severe cases of diarrhea, sometimes involving bacteremia or hypovolemic shock (<link linkend="ch0061s000000li0065">65</link>). Most recorded cases of infection involve a history of consumption of seafood, such as oysters. <emphasis>V. metschnikovii</emphasis> is frequently isolated from freshwater and brackish and marine waters. It was first reported to cause peritonitis and bacteremia in a patient with an inflamed gallbladder. Since then, it has been isolated from additional patients with bacteremia and, rarely, from wound infections; it has also been isolated from cases of cholecystitis, diarrhea, and pneumonia (<link linkend="ch0061s000000li0066">66</link>, <link linkend="ch0061s000000li0067">67</link>). <emphasis>Vibrio cincinnatiensis</emphasis> was first isolated from a patient with bacteremia and meningitis. Subsequent isolates have been recovered from the stool of a person with diarrhea and two aborted bovine fetuses (<link linkend="ch0061s000000li0068">68</link>). The Washington State Department of Health confirmed its first fatal case of this organism from the blood of a patient with rapidly progressing cellulitis, bacteremia, and septic shock in 2016. A novel species closely related to <emphasis>V. metschnikovii</emphasis> and <emphasis>V. cincinnatiensis</emphasis>, named <emphasis>Vibrio injensis</emphasis>, was recently identified in human clinical specimens in South Korea; however, its pathogenic potential is unclear (<link linkend="ch0061s000000li0015">15</link>). CDC has observed five additional <emphasis>Vibrio</emphasis> species that have occasionally been isolated from human clinical specimens. Three species, <emphasis>Vibrio metoecus</emphasis> (<link linkend="ch0061s000000li0006">6</link>), <emphasis>V. paracholerae</emphasis> (<link linkend="ch0061s000000li0004">4</link>) and <emphasis>V. tarriae</emphasis> (<link linkend="ch0061s000000li0005">5</link>), are closely related to <emphasis>V. cholerae.</emphasis> Like their close relative, they are sucrose positive and nonhalophilic. <emphasis>Vibrio navarrensis</emphasis> is a halophilic species first isolated from sewage (<link linkend="ch0061s000000li0069">69</link>). The CDC used <emphasis>rpoA</emphasis> sequencing and phylogenetic analysis (<link linkend="ch0061s000000li0070">70</link>) to identify 15 human isolates collected since 1983 as <emphasis>V. navarrensis</emphasis> (<link linkend="ch0061s000000li0071">71</link>). A species closely related to <emphasis>V. navarrensis, Vibrio cidicii</emphasis>, was recently described (<link linkend="ch0061s000000li0014">14</link>). Like <emphasis>V. navarrensis, V. cidicii</emphasis> has been isolated from freshwater environments and from cases of diarrhea and extraintestinal infections, but its causative role in disease requires additional investigation.</para>
      <sect2 id="ch0061s0012s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0061s000012a0002"/>
        <anchor id="ch0061s000000a0046"/>
        <para id="ch0061s000000p0022">Pertinent clinical histories (when known) should accompany specimens to alert the laboratory to include appropriate isolation media for the<emphasis>Vibrionaceae</emphasis> in their stool workup; this is especially important in areas where the isolation of <emphasis>Vibrio</emphasis> is infrequent (<link linkend="ch0061s000000li0072">72</link>). Helpful information includes history of travel, consumption of raw shellfish and other seafood, activity associated with marine or brackish water (or wounds associated with such exposure), and hobbies associated with aquaria.</para>
        <para id="ch0061s000000p0023"><emphasis>Vibrionaceae</emphasis> are particularly susceptible to drying, so stool specimens that cannot be inoculated onto plating media within 2 to 4 h should be placed in a transport medium. Cary-Blair or any noninhibitory transport medium is acceptable for <emphasis>Vibrio</emphasis> isolation. For specimens collected in the field, if necessary, liquid stool may be placed on strips of blotting paper or gauze and then inserted in airtight plastic bags with a few drops of saline to maintain moisture and sent to the laboratory. Detailed information on the collection and transport of specimens for <emphasis>Vibrio</emphasis> isolation is available elsewhere (<link linkend="ch0061s000000li0073">73</link>). Special methods for the collection and processing of extraintestinal specimens (blood, wounds, etc.) for <emphasis>Vibrio</emphasis> isolation are not required, as <emphasis>Vibrio</emphasis> organisms are, as a rule, isolated in pure culture from these sites and the concentration of salt in primary plating media is usually sufficient for their recovery. Upon isolation, however, salt may need to be added to subsequent media to attain growth of salt-requiring vibrios. <emphasis>Vibrionaceae</emphasis> may die within weeks <emphasis>in vitro</emphasis>, even in moist environments at room temperature, and should be maintained at −70°C in tryptic soy broth with 15% glycerol as directed in <ulink url="ch0028#ch0028s0001">chapter 13</ulink> of this <emphasis>Manual</emphasis>.</para>
        <anchor id="ch0061s000000a0047"/>
        <beginpage pagenum="860"/>
      </sect2>
      <sect2 id="ch0061s0012s0002">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0061s000012a0003"/>
        <anchor id="ch0061s000000a0048"/>
        <para id="ch0061s000000p0024">Direct microscopic detection of vibrios in stool is not routinely recommended, since it may not be possible to distinguish pathogenic vibrios from other members of the enteric microbiota.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0061s0013">
      <title>Direct Detection of V. cholerae O1 in Stool</title>
      <anchor id="ch0061s000013a0001"/>
      <anchor id="ch0061s000000a0049"/>
      <para id="ch0061s000000p0025">Direct detection of<emphasis>V. cholerae</emphasis> from stool is typically conducted only in laboratories in areas where cholera is epidemic or endemic or in field situations where laboratory services are unavailable and rapid diagnosis is required. One of the oldest assays, the microscopic immobilization test, detects loss of motility of <emphasis>V. cholerae</emphasis> O1 organisms by the addition of O1 antibody and can be used to detect <emphasis>V. cholerae</emphasis> O139 by using O139 antibody. Two membrane antigen rapid tests, Smart Cholera O1 (sensitivity, 83%; specificity, 88%) and Bengal Smart O139 (sensitivity, 100%; specificity, 97%), are available from New Horizons Diagnostics Corp. (Columbia, MD). Two rapid immunochromatographic dipstick assays, which detect the presence of <emphasis>V. cholerae</emphasis> O1 or O139 antigens in stool, are commercially available from Span Diagnostics (Surat, India) and Standard Diagnostics (Kyonggi-do, South Korea). The Span Crystal Vc for O1 and O139 demonstrated a sensitivity of 92% and a specificity of 73% (<link linkend="ch0061s000000li0074">74</link>). For the SD Bioline Cholera Ag O1/O139 test (Abbott, Abbot Park, IL), the manufacturer claims a sensitivity of 100% for the O1 antigen and 100% for O139, with respective specificities of 100% and 100%. During an outbreak in Zambia, a study demonstrated a sensitivity of 91% and specificity of 95% (<link linkend="ch0061s000000li0075">75</link>).</para>
    </sect1>
    <sect1 id="ch0061s0014">
      <title>Molecular Detection in Clinical Specimens</title>
      <anchor id="ch0061s000014a0001"/>
      <anchor id="ch0061s000000a0050"/>
      <para id="ch0061s000000p0026">Publications on molecular methodologies for detection of<emphasis>V. cholerae, V. parahaemolyticus</emphasis>, and <emphasis>V. vulnificus</emphasis> specifically in stool can be found in the literature starting in the 1990s and are too numerous to cover here. Few of these tests are commercially available. Most of the advantages of PCR-based assays over culture methods apply to vibrios and include the ability to freeze stool samples for epidemiological studies for delayed testing. In areas where vibrios are rarely isolated and laboratory experience or resources are limited, molecular methods may be more practical and provide reliable results than culture with a shorter turnaround time. Inhibitors in stool may affect the analytical sensitivity of a PCR assay but can be overcome by dilution of the sample. Laboratory-developed nucleic acid amplification tests for <emphasis>V. cholerae</emphasis> use a multiplex PCR that includes primers for the <emphasis>ctxA</emphasis> gene, <emphasis>rfb</emphasis> genes (O antigens O1 and O139, allowing differentiation of serotypes), and <emphasis>tcpA</emphasis> genes (specific for the El Tor and classical biotypes); co-occurrence of these three genes can be interpretable as the El Tor or classical biotype (<link linkend="ch0061s000000li0076">76</link>, <link linkend="ch0061s000000li0077">77</link>). For clinical strains of <emphasis>V. parahaemolyticus</emphasis>, the thermostable direct hemolysin, a major virulence determinant, is a common target for detection, but it is not universally present in strains isolated from human infections (<link linkend="ch0061s000000li0078">78</link>, <link linkend="ch0061s000000li0079">79</link>).</para>
      <para id="ch0061s000000p0027">Commercially available syndromic gastrointestinal panels offer detection of vibrios from stool. Currently, FDA-cleared assays include the Verigene enteric pathogen test (Verigene EP; Luminex Corporation), the Luminex xTAG gastrointestinal pathogen panel (Luminex GPP; Luminex Corporation), the BioFire FilmArray gastrointestinal panel (BioFire GIP; bioMérieux), BD Max extended enteric bacterial panel (BD Max xEBP; BD), and the Applied BioCode gastrointestinal panel (BioCode GPP; Applied BioCode) (<link linkend="ch0061s000000li0080">80</link>). Depending on the assay, unpreserved stool or stool samples preserved in Cary-Blair medium undergo PCR-based pathogen detection, with a time to result of 1 to 5 h. It is important to note that these panels vary in detecting a limited number of clinically relevant <emphasis>Vibrio</emphasis> species (<emphasis>V. cholerae, V. parahaemolyticus</emphasis>, and <emphasis>Vibrio vulnificus</emphasis>) they can detect and differentiate (<anchor id="ch0061s000000a0051"/><link linkend="ch0061s000000a0053">Table 3</link>). The use of commercial syndromic GI panels has increased steadily since FDA clearance of these testing methods in 2014 (FoodNet Fast, CDC). The greater sensitivity from utilization of syndromic GI panels does present certain challenges with regard to result interpretation for vibrios which represent lower-prevalence pathogens on these panels. Viable and nonviable organisms as well as transient nucleic acid can all be detected by these assays, highlighting the importance of clinical context in interpretation (<link linkend="ch0061s000000li0081">81</link>). False-positive results have been described for vibrios (<link linkend="ch0061s000000li0082">82</link>) as well as a low rate of culture confirmation, that is, recovery of <emphasis>Vibrio</emphasis> isolates from reflexed positive specimens (<link linkend="ch0061s000000li0083">83</link>). Current explanations for discrepancies between positive panel results and culture recovery that have been described for vibrios include low levels of organisms, cross-reactivity with other organisms, and low levels of contaminating nucleic acid introduced into Cary-Blair medium, reagents, or samples during the manufacturing or testing process (BioFire technical note FLM1-PRT-0239-03). When feasible, laboratories should attempt to culture confirm positive <emphasis>Vibrio</emphasis> results from GI syndromic panels.</para>
      <anchor id="ch0061s000000a0052"/>
      <beginpage pagenum="861"/>
      <table id="ch0061s000000t0003"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0061s000000a0053"/><link linkend="ch0061s000000a0051">TABLE 3</link></phrase></emphasis> <emphasis>Vibrio</emphasis> species and gene target information for commercial gastrointestinal multiplex panels<superscript><emphasis><anchor id="ch0061s000000a0054"/><link linkend="ch0061s000000a0056">a</link></emphasis>,<emphasis><anchor id="ch0061s000000a0055"/><link linkend="ch0061s000000a0057">b</link></emphasis></superscript>
</title>
        
        <tgroup cols="4">
          <tbody>
            <row>
              <entry><phrase role="center">Multiplex gastrointestinal panel</phrase>
              </entry>
              <entry><phrase role="center"><emphasis>Vibrio</emphasis> species detected</phrase>
              </entry>
              <entry><phrase role="center"><emphasis>Vibrio</emphasis> gene target(s)</phrase>
              </entry>
              <entry><phrase role="center">Comments</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Luminex GPP xTAG</phrase>
              </entry>
              <entry><phrase role="left">
                  <emphasis>V. cholerae</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left">Cholera toxin (<emphasis>ctx</emphasis>)</phrase>
              </entry>
              <entry><phrase role="left">Only strains that express <emphasis>ctx</emphasis> are detected</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Verigene enteric pathogens (Luminex)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Vibrio</emphasis> group (<emphasis>V. cholerae, V. parahaemolyticus)</emphasis></phrase>
              </entry>
              <entry><phrase role="left">
                  <emphasis>rfbL, trkH, tnaA</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left">Unable to differentiate species</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">BD MAX extended enteric bacterial panel</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Vibrio</emphasis> (<emphasis>V. cholerae, V. vulnificus, V. parahaemolyticus</emphasis>)</phrase>
              </entry>
              <entry><phrase role="left">Not provided</phrase>
              </entry>
              <entry><phrase role="left">Unable to differentiate species</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">FilmArray gastrointestinal panel (BioFire)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Vibrio</emphasis> (<emphasis>V. cholerae, V. vulnificus, V. parahaemolyticus</emphasis>)</phrase>
              </entry>
              <entry><phrase role="left">
                  <emphasis>gyrB</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Vibrio</emphasis> target unable to differentiate species; not specific to the three species listed</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left">
                  <emphasis>V. cholerae</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left">
                  <emphasis>toxR</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left">Differentiates <emphasis>V. cholerae</emphasis> from other species</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Applied BioCode gastrointestinal panel</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Vibrio</emphasis> (<emphasis>V. cholerae, V. vulnificus, V. parahaemolyticus</emphasis>)</phrase>
              </entry>
              <entry><phrase role="left">Not provided</phrase>
              </entry>
              <entry><phrase role="left">Unable to differentiate species</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left">
                  <emphasis>V. parahaemolyticus</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="left">Not provided</phrase>
              </entry>
              <entry><phrase role="left">Specifically identifies <emphasis>V. parahaemolyticus</emphasis></phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0056"/><link linkend="ch0061s000000a0054">a</link></emphasis></superscript>Information derived from available product package inserts and 510(K) data as provided.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0061s000000a0057"/><link linkend="ch0061s000000a0055">b</link></emphasis></superscript>Prodesse ProGastro SSCS (Hologic) does not detect <emphasis>Vibrio.</emphasis></para>
      <sect2 id="ch0061s0014s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0061s000014a0002"/>
        <anchor id="ch0061s000000a0058"/>
        <para id="ch0061s000000p0028"><emphasis>Vibrionaceae</emphasis> associated with human disease can be isolated from routine enteric media, but recovery is enhanced when specific media are used. On MacConkey or <emphasis>Salmonella</emphasis>-<emphasis>Shigella</emphasis> agar, vibrios (with the exception of the rapidly lactose-fermenting strains of <emphasis>V. vulnificus</emphasis>) present as colorless colonies. Some strains of <emphasis>V. cholerae</emphasis> are inhibited on MacConkey and <emphasis>Salmonella</emphasis>-<emphasis>Shigella</emphasis> agar. On sucrose-containing media, such as Hektoen agar and xylose-lysine-deoxycholate (XLD), sucrose-positive vibrios associated with human disease, such as <emphasis>V. cholerae, V. fluvialis, V. alginolyticus</emphasis>, and some strains of <emphasis>V. vulnificus</emphasis>, cannot be differentiated from strains of other enteric bacteria that rapidly ferment sucrose. The addition of a blood agar plate allows colonies to be screened for oxidase, which may improve the recovery of vibrios as well as colonies of <emphasis>Aeromonas</emphasis> species and <emphasis>Plesiomonas shigelloides. G. hollisae</emphasis> may grow poorly or not at all on any enteric isolation medium, including TCBS medium; it is probably most reliably isolated from blood agar.</para>
        <para id="ch0061s000000p0029">TCBS agar is formulated specifically for the isolation of vibrios (<link linkend="ch0061s000000li0002">2</link>). Both powdered formulations and prepared plates are available from a number of commercial sources. Inclusion of sucrose allows preliminary differentiation of <emphasis>Vibrio</emphasis> species, with <emphasis>V. cholerae, V. metoecus, V. paracholerae, V. tarriae, V. fluvialis</emphasis>, and <emphasis>V. alginolyticus</emphasis> producing yellow colonies, while <emphasis>V. parahaemolyticus, V. mimicus</emphasis>, and most strains of <emphasis>V. vulnificus</emphasis> produce green colonies (sucrose is not fermented). It should be noted that yellow colonies may convert to green if plates are examined after more than 24 h or are refrigerated after incubation. Oxidase testing is unreliable when performed directly on colonies growing on this medium. Growth from a non-sugar-containing medium, such as blood or nutrient agar, should be used for oxidase testing.</para>
        <para id="ch0061s000000p0030">A chromogenic agar, CHROMagar<emphasis>Vibrio</emphasis> (CHROMagar Microbiology, Paris, France), has been developed primarily for the recovery of <emphasis>V. parahaemolyticus</emphasis> from seafood and supports the growth of other vibrios as well (<link linkend="ch0061s000000li0084">84</link>). <emphasis>Vibrio</emphasis> colonies on this medium range in color from milk white to pale blue to violet. Other members of the enteric microbiota usually do not grow, with the exception of <emphasis>Proteus mirabilis</emphasis> and <emphasis>Providencia rettgeri</emphasis>, which also produce milk white colonies. Marine agar (BD Biosciences, Sparks, MD), which does not contain any inhibitory or selective ingredients, may be more appropriate for isolation of vibrios from the environment, especially salt-requiring vibrios, because of its high salt content.</para>
        <para id="ch0061s000000p0031">It is common for pure cultures of vibrios to produce multiple colony morphologies (as many as five) on any medium, but this phenomenon is most readily noticeable on nonselective media, such as blood and heart infusion agars. Variations in morphology include smooth, rough, convex, flat, spreading, and compact cells in various combinations. Occasionally,<emphasis>V. cholerae</emphasis> produces rugose (extremely wrinkled) colonies on non-carbohydrate-containing media (<link linkend="ch0061s000000li0085">85</link>). Like their smooth counterparts, they are fully virulent for humans (<link linkend="ch0061s000000li0086">86</link>). Rugosity, which is due to production of a unique extracellular polysaccharide, confers biofilm formation and resistance to chlorine, acid pH, and serum killing (<link linkend="ch0061s000000li0085">85</link>, <link linkend="ch0061s000000li0086">86</link>). Although it is believed to enhance survival in aquatic environments, to date it has been demonstrated only <emphasis>in vitro.</emphasis> Isolates of the classical biotype of <emphasis>V. cholerae</emphasis> also possess the <emphasis>vps</emphasis> (vibrio polysaccharide synthesis) gene cluster, which encodes this phenotype, but rugose variants have been demonstrated only from El Tor strains (<link linkend="ch0061s000000li0086">86</link>).</para>
        <para id="ch0061s000000p0032">In acute diarrheal disease, stool enrichment is generally not required; however, when enrichment is necessary, alkaline peptone water (1% NaCl, pH 8.5) is the most commonly used enrichment broth for human specimens. It should be incubated at 36°C and subcultured at 6 h and 18 h on TCBS medium.</para>
      </sect2>
      <sect2 id="ch0061s0014s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0061s000014a0003"/>
        <anchor id="ch0061s000000a0059"/>
      </sect2>
    </sect1>
    <sect1 id="ch0061s0015">
      <title>Conventional Phenotypic Tests</title>
      <anchor id="ch0061s000015a0001"/>
      <anchor id="ch0061s000000a0060"/>
      <para id="ch0061s000000p0033">Phenotypic properties that separate members of the<emphasis>Vibrionaceae</emphasis> from the <emphasis>Enterobacterales</emphasis> and the <emphasis>Aeromonadaceae</emphasis> are found in <link linkend="ch0061s000000a0008">Table 1</link>, and historical phenotypic profiles of 12 species that occur in human clinical specimens are given in <link linkend="ch0061s000000a0021">Table 2</link>. Newer <emphasis>Vibrio</emphasis> species (<emphasis>V. paracholerae, V. tarriae, V. metoecus, V. cidicii, V. navarrensis</emphasis>, and <emphasis>V. injensis</emphasis>) more recently identified from clinical specimens are omitted from this table, as only a limited number of phenotypically characterized isolates are available. Additionally, conventional phenotypic methods alone are not sufficient to identify all of these species. Many commercial standard tube tests have sufficient salt to support growth without salt supplementation (0.5 to 1%), but some tests—such as the Voges-Proskauer test, Moeller’s test for decarboxylases and dihydrolase, and the nitrate broth test—may contain no NaCl or insufficient NaCl to support the growth of some NaCl-requiring strains, and these tests’ media should always have salt added to them (to a final concentration of 1%).</para>
      <para id="ch0061s000000p0034">It should be noted that many<emphasis>V. cholerae</emphasis> O1 strains from Bangladesh and surrounding areas and all strains of <emphasis>V. cholerae</emphasis> O139 are resistant to both 10- and 150-μg disks of the vibriostatic compound O/129 (Remel, Lenexa, KS), a test historically used to distinguish vibrios (<link linkend="ch0061s000000a0008">Table 1</link>). In areas of the world where cholera is uncommon, all cultures identified as <emphasis>V. cholerae</emphasis> should be sent to public health laboratories for further characterization, including O1 and O139 agglutination and nucleic acid amplification tests for the presence of the <emphasis>ctxA</emphasis> and <emphasis>tcpA</emphasis> genes (or <emphasis>in silico</emphasis> detection of these characteristics from genome sequences). Traditionally, El Tor biotypes have been differentiated by a number of phenotypic tests, including hemolysis of sheep erythrocytes, production of acetylmethylcarbinol (Voges-Proskauer test), and resistance to polymyxin B (<link linkend="ch0061s000000li0026">26</link>). Except in their serogroup and O/129 reactions, <emphasis>V. cholerae</emphasis> O139 strains are phenotypically similar to <emphasis>V. cholerae</emphasis> O1 El Tor strains. Strains of <emphasis>V. cholerae</emphasis> that fail to agglutinate in either O1 or O139 antiserum are reported as <emphasis>V. cholerae</emphasis> non-O1. Serogrouping for non-O1 strains is available in a limited number of reference laboratories, which typically use only some of many possible sera.</para>
      <anchor id="ch0061s000000a0061"/>
      <beginpage pagenum="862"/>
      <para id="ch0061s000000p0035"><emphasis>V. cholerae, V. metoecus, V. paracholerae, V. tarriae</emphasis>, and <emphasis>V. mimicus</emphasis> are distinguished from other species by growth in media lacking NaCl (Difco, BD Biosciences; nutrient broth may be the only broth that accurately determines NaCl requirement). Strains of <emphasis>V. parahaemolyticus, V. alginolyticus</emphasis>, and <emphasis>P. damselae</emphasis> may be urea positive. Most vibrios isolated from humans produce a buff or tan pigment; however, strains of <emphasis>V. parahaemolyticus</emphasis> may produce a dark-brown pigment. <emphasis>G. hollisae</emphasis> generally grows poorly, especially in Moeller’s decarboxylase and dihydrolase broths, even after salt supplementation, and produces extremely large zones of inhibition, often necessitating the use of two plates when disk diffusion antimicrobial susceptibility testing is performed. <emphasis>V. metschnikovii</emphasis> is distinctive because it is an oxidase- and nitrate-negative <emphasis>Vibrio</emphasis> sp. <emphasis>V. fluvialis</emphasis> and <emphasis>V. furnissii</emphasis> are frequently confused with <emphasis>Aeromonas caviae</emphasis> (synonym <emphasis>Aeromonas punctata</emphasis>), especially because some strains are weakly halophilic and only moderately susceptible to O/129, and because some strains of <emphasis>A. caviae</emphasis> grow on TCBS agar. <emphasis>V. furnissii</emphasis> is the only <emphasis>Vibrio</emphasis> isolated from humans that is positive for gas production from <phrase role="small">D</phrase>-glucose. Rapid, correct identification of <emphasis>V. vulnificus</emphasis> strains is critical because of the mortality associated with this organism. Some strains of <emphasis>V. vulnificus</emphasis> are sucrose positive, which may add to the confusion in identifying it. The phenotypic characteristics of <emphasis>V. navarrensis</emphasis> and <emphasis>V. cidicii</emphasis> are similar to those of <emphasis>V. vulnificus</emphasis>, except for the notable difference of negative test results for ornithine and lysine decarboxylase (<link linkend="ch0061s000000li0071">71</link>). <emphasis>V. cidicii</emphasis> can be differentiated from <emphasis>V. navarrensis</emphasis> by its utilization of <phrase role="small">L</phrase>-rhamnose (<link linkend="ch0061s000000li0014">14</link>).</para>
    </sect1>
    <sect1 id="ch0061s0016">
      <title>Commercial Systems</title>
      <anchor id="ch0061s000016a0001"/>
      <anchor id="ch0061s000000a0062"/>
      <para id="ch0061s000000p0036">There are no recent studies evaluating commercial systems’ abilities to identify organisms covered in this chapter; however, identification of these organisms by commercial systems is problematic. Commercial systems are constantly changing and updating their databases, so the reader is urged to consult current information about the status of the database. One evaluation that compared six commercial systems (<link linkend="ch0061s000000li0087">87</link>) indicated that when tested only against species listed in their databases, API 20E (bioMérieux, Inc., Durham, NC), Crystal E/NF (BD Biosciences), MicroScan Neg ID type 2 and type 3 (Siemens Healthcare Systems, West Sacramento, CA), and Vitek GNI+ and ID-GNB cards (bioMérieux) correctly identified only 63 to 81% of these organisms to the species level. Correct identifications of three commonly isolated species of <emphasis>Vibrio</emphasis> from clinical samples varied. For <emphasis>V. cholerae</emphasis>, API 20E gave the least (50%) and Crystal E/NF the most (97%) accurate identification. For <emphasis>V. parahaemolyticus</emphasis>, Rapid Neg ID3 fared the worst (40%) and API 20E and GNI+ the best (97% each), while for <emphasis>V. vulnificus</emphasis> biogroup 1 strains, GNI+ (50%) and Crystal E/NF (97%) gave the lowest and highest rates, respectively. Only Crystal E/NF was able to correctly identify ≥90% of <emphasis>V. cholerae</emphasis> or <emphasis>V. vulnificus</emphasis> strains, and only API 20E and the two Vitek cards correctly identified ≥90% of <emphasis>V. parahaemolyticus</emphasis> strains. In another study using only <emphasis>V. vulnificus</emphasis> biotype 3 strains, the MicroScan (98%) and Phoenix (90%) systems did the best in identifying 51 well-characterized isolates to the correct species, while the identification rate with Vitek (14%) was much less satisfactory (<link linkend="ch0061s000000li0086">86</link>). Croci et al. (<link linkend="ch0061s000000li0088">88</link>) found that for the identification of <emphasis>V. parahaemolyticus</emphasis>, API 20NE exhibited greater sensitivity than API 20E (20 versus 16 of 27 specimens) but API 20E was more specific (100% versus 82%). In another study of a mixture of 111 clinical and environmental <emphasis>V. vulnificus</emphasis> strains, API 20E, API 20NE, and Biolog (Biolog, Inc., Hayward, CA) correctly identified 60, 0, and 85% of strains, respectively (<link linkend="ch0061s000000li0089">89</link>). Manufacturers’ instructions should be checked prior to testing of salt-requiring vibrios to determine if salt supplementation is required. One publication indicated that API 20E gave incorrect identifications for clinical isolates of <emphasis>V. parahaemolyticus</emphasis> if 2.0% NaCl was used for the diluent, versus 0.85% (<link linkend="ch0061s000000li0088">88</link>).</para>
    </sect1>
    <sect1 id="ch0061s0017">
      <title>Molecular Methods</title>
      <anchor id="ch0061s000017a0001"/>
      <anchor id="ch0061s000000a0063"/>
      <para id="ch0061s000000p0037">Species-level identification of many of the less common and newer vibrios requires the utilization of molecular methods that offer advantages over traditional phenotypic methods. Various molecular approaches used to differentiate<emphasis>Vibrio</emphasis> species are described in the literature. The use of 16S rRNA gene sequencing alone is less than ideal for <emphasis>Vibrionaceae</emphasis> identification, because interspecies sequence differences can be very small and polymorphism has been shown to be fairly common in 16S rRNA genes (<link linkend="ch0061s000000li0090">90</link>). Tarr et al. (<link linkend="ch0061s000000li0064">64</link>) developed a multiplex PCR assay, using primers directed at <emphasis>V. cholerae sodB, V. mimicus sodB, V. parahaemolyticus flaE</emphasis>, and <emphasis>V. vulnificus hsp</emphasis> genes, that correctly identified 109 isolates and found an additional 4 strains of <emphasis>V. parahaemolyticus</emphasis> that either had not been identified to the species level (<emphasis>n</emphasis> = 3) or had been identified incorrectly as <emphasis>V. alginolyticus</emphasis> (<emphasis>n</emphasis> = 1). Additionally, <emphasis>rpoB</emphasis> gene sequencing has been used to identify 12 of 15 isolates not previously identified to the species level by phenotypic methods and led to the discovery of <emphasis>V. cidicii</emphasis> (<link linkend="ch0061s000000li0014">14</link>) and <emphasis>V. metoecus</emphasis> (<link linkend="ch0061s000000li0006">6</link>). <emphasis>V. paracholerae</emphasis> was first identified by sequencing of the <emphasis>viuB</emphasis> gene (<link linkend="ch0061s000000li0004">4</link>), which also provides subspecies resolution for <emphasis>V. cholerae</emphasis> and can distinguish O1/O139 pandemic strains from other lineages (<link linkend="ch0061s000000li0006">6</link>). Multilocus sequence analysis using <emphasis>rpoA, recA</emphasis>, and <emphasis>pyrH</emphasis> gene segments has also been shown to cluster <emphasis>Vibrio</emphasis> species into distinct groups that are roughly consistent with established taxonomy (<link linkend="ch0061s000000li0070">70</link>). Methods that assess genetic relatedness from genome sequences, either through phylogenetic analysis (<link linkend="ch0061s000000li0091">91</link>) or genotypic analyses, such as average nucleotide identity (<link linkend="ch0061s000000li0092">92</link>) and digital DNA-DNA hybridization (<link linkend="ch0061s000000li0093">93</link>), will likely replace traditional workflows to identify species in the near future. When combined with core genome multilocus sequence typing (cgMLST) or phylogenetic analysis of single nucleotide polymorphisms, genome sequencing also enables identification and characterization of bacterial isolates to the level of subtyping that is useful for outbreak investigations with a single workflow (<link linkend="ch0061s000000li0094">94</link>).</para>
      <para id="ch0061s000000p0038">Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has become a valuable tool for rapid identification of closely related bacterial species, with a rapid turnaround time and modest test cost. MALDI-TOF MS produced phylogenetic classification results comparable to those of<emphasis>rpoB</emphasis> sequencing for <emphasis>Vibrio</emphasis> species (<link linkend="ch0061s000000li0095">95</link>). A multicenter evaluation of the Vitek MS v.2.0 (bioMérieux) (<link linkend="ch0061s000000li0096">96</link>) included only the three commonly isolated species (<emphasis>V. parahaemolyticus, V. vulnificus</emphasis>, and <emphasis>V. cholerae</emphasis>) and correctly identified about 90% of the isolates within each species. Data are limited on the performance of MALDI-TOF MS for less commonly encountered species (e.g., <emphasis>V. metschnikovii</emphasis>) and for close relatives (e.g., <emphasis>V. alginolyticus</emphasis> and <emphasis>V. mimicus</emphasis>) of the three common species. <emphasis>V. parahaemolyticus</emphasis> and <emphasis>V. vulnificus</emphasis> are in the FDA-cleared databases of both the Bruker Biotyper CA (Bruker Daltonics, Billerica, MA) and Vitek MS systems. However, it should be noted that <emphasis>V. cholerae</emphasis> is also in the FDA-cleared Vitek MS database but is currently not in the main spectrum database of the Bruker Biotyper. Additionally, newly characterized species, which include <emphasis>V. paracholerae, V. tarriae, V. metoecus, V. cidicii</emphasis>, and <emphasis>V. injensis</emphasis>, are absent from current databases. Laboratories using MALDI-TOF MS systems in the routine identification of vibrios should be well versed in which species are included in the database version being utilized as well as differences between databases (research use only [RUO] versus FDA cleared) within and between systems (Biotyper versus Vitek MS). When evaluating <emphasis>Vibrio</emphasis> species in MALDI-TOF MS databases, it is recommended that species-level identification be validated by an alternative method prior to accepting identifications for clinical use.</para>
      <anchor id="ch0061s000000a0064"/>
      <beginpage pagenum="863"/>
    </sect1>
    <sect1 id="ch0061s0018">
      <title>V. cholerae and V. parahaemolyticus Toxin Detection</title>
      <anchor id="ch0061s000018a0001"/>
      <anchor id="ch0061s000000a0065"/>
      <para id="ch0061s000000p0039">Historically, reference laboratories detected cholera toxin by fluid accumulation in animal assays or detection of a cytopathic effect in Y1 adrenal or Chinese hamster ovary cell cultures. A reverse passive latex agglutination (VET-RPLA) assay (Denka Seiken) which detects both cholera toxin and the heat-labile toxin of<emphasis>Escherichia coli</emphasis> is commercially available. It is now more common to screen isolates for the presence of the <emphasis>ctxA</emphasis> gene using multiplex PCR (<link linkend="ch0061s000000li0076">76</link>, <link linkend="ch0061s000000li0077">77</link>). A majority of human strains of <emphasis>V. parahaemolyticus</emphasis> produce a thermostable direct hemolysin encoded by two genes, <emphasis>tdh</emphasis> and <emphasis>tdh2x.</emphasis> These toxins are rarely produced by environmental strains of <emphasis>V. parahaemolyticus</emphasis> but have been detected in <emphasis>V. cholerae</emphasis> non-O1, <emphasis>V. mimicus</emphasis>, and <emphasis>G. hollisae</emphasis> strains. Like cholera toxin, thermostable direct hemolysin can be detected by a commercial latex assay (KAP-RPLA; Denka Seiken), but there are no commercial products that detect the related thermostable hemolysin (<emphasis>trh</emphasis>) seen in <emphasis>V. parahaemolyticus.</emphasis> PCR assays for cholera toxin genes and both <emphasis>V. parahaemolyticus</emphasis> hemolysins have been developed but are not commercially available (<link linkend="ch0061s000000li0097">97</link>).</para>
      <sect2 id="ch0061s0018s0001">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0061s000018a0002"/>
        <anchor id="ch0061s000000a0066"/>
      </sect2>
    </sect1>
    <sect1 id="ch0061s0019">
      <title>Serotyping</title>
      <anchor id="ch0061s000019a0001"/>
      <anchor id="ch0061s000000a0067"/>
      <para id="ch0061s000000p0040">Serotyping is still used for subtyping of<emphasis>V. cholerae</emphasis> and is routinely performed in public health laboratories; however, serotyping of <emphasis>V. parahaemolyticus</emphasis> is rarely performed today. Typing schemes have been described for a number of species, including <emphasis>V. cholerae, V. parahaemolyticus</emphasis>, and <emphasis>V. vulnificus</emphasis>; however, commercial typing sera are available only for <emphasis>V. cholerae</emphasis> and <emphasis>V. parahaemolyticus. V. cholerae</emphasis> O1 (polyclonal, Inaba and Ogawa) and O139 antisera are available from BD Biosciences, Denka Seiken, Remel, and New Horizons. <emphasis>V. parahaemolyticus</emphasis> antisera (11 O groups and 9 polyvalent and 65 monovalent K groups) are available from Denka Seiken.</para>
    </sect1>
    <sect1 id="ch0061s0020">
      <title>Molecular Typing of Vibrios</title>
      <anchor id="ch0061s000020a0001"/>
      <anchor id="ch0061s000000a0068"/>
      <para id="ch0061s000000p0041">Traditionally, methods such as pulsed-field gel electrophoresis using NotI and SfiI enzymes were standardized approaches to molecular typing of vibrios for surveillance purposes (<link linkend="ch0061s000000li0098">98</link>, <link linkend="ch0061s000000li0099">99</link>). For <emphasis>V. vulnificus</emphasis>, repetitive extragenic palindromic PCR is an effective subtyping method (<link linkend="ch0061s000000li0100">100</link>). Genotyping systems based on nucleotide sequence polymorphisms in several genes (16S rRNA gene, <emphasis>vvhA</emphasis>, and <emphasis>vcg</emphasis>) were originally thought to distinguish clinical from environmental isolates, but these methods do not clearly differentiate pathogenic from nonpathogenic strains of <emphasis>V. vulnificus</emphasis> (<link linkend="ch0061s000000li0089">89</link>). Phylogenetic analysis of housekeeping genes has revealed two distinct lineages of <emphasis>V. vulnificus</emphasis>, with both environmental and clinical isolates falling into each of the lineages (<link linkend="ch0061s000000li0100">100</link>). MLST has been useful in resolving the population structure of <emphasis>V. parahaemolyticus</emphasis> strains in the northwestern United States and elsewhere, and the technique allows identification of the pandemic clone (<link linkend="ch0061s000000li0101">101</link>). In addition to <emphasis>V. parahaemolyticus</emphasis>, MLST schemes are available for the other two commonly isolated species (<emphasis>V. cholerae</emphasis> and <emphasis>V. vulnificus</emphasis>) (<ulink url="http://www.pubmlst.org">http://www.pubmlst.org</ulink>). All of these subtyping methods are being replaced by whole-genome sequencing and <emphasis>in silico</emphasis> analysis of traditional epidemiological markers (<link linkend="ch0061s000000li0094">94</link>). A core genome MLST method has been developed for <emphasis>V. parahaemolyticus</emphasis> (<link linkend="ch0061s000000li0101">101</link>) and <emphasis>V. cholerae</emphasis> (<link linkend="ch0061s000000li0102">102</link>), which provides the level of discrimination needed for outbreak investigation. Phylogenetic analysis of single nucleotide polymorphisms extracted from whole-genome sequencing in <emphasis>V. cholerae</emphasis> has revealed at least 11 introductions of <emphasis>V. cholerae</emphasis> O1 from Asia into Africa since 1970, causing epidemics that have lasted up to 28 years (<link linkend="ch0061s000000li0103">103</link>). Similar genomic analyses were also crucial in showing that the cholera epidemic in Haiti resulted from a single introduction from an outside source, most likely Nepal (<link linkend="ch0061s000000li0104">104</link>, <link linkend="ch0061s000000li0105">105</link>). Genomic analyses also show that the sublineage which led to the 2016 Yemen epidemic originated from South Asia and that it caused outbreaks in East Africa before appearing in Yemen (<link linkend="ch0061s000000li0106">106</link>).</para>
      <sect2 id="ch0061s0020s0001">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0061s000020a0002"/>
        <anchor id="ch0061s000000a0069"/>
        <para id="ch0061s000000p0042">Reagents for the serodiagnosis of cholera are available only in specialized reference laboratories, but titration of acute- and convalescent-phase sera in agglutination, vibriocidal, or antitoxin tests is considered reliable (<link linkend="ch0061s000000li0107">107</link>).</para>
      </sect2>
      <sect2 id="ch0061s0020s0002">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0061s000020a0003"/>
        <anchor id="ch0061s000000a0070"/>
        <para id="ch0061s000000p0043">Generally, for most<emphasis>V. cholerae</emphasis> and <emphasis>V. parahaemolyticus</emphasis> gastrointestinal infections, treatment by rehydration is recommended over antimicrobial therapy and has the added benefit of reducing the risk of antimicrobial resistance. Antimicrobial therapy, however, can reduce the duration of diarrhea, the duration of shedding of the organism, and the volume of rehydration fluid needed for recovery, and patients are often treated before culture results are known (<link linkend="ch0061s000000li0034">34</link>). Dehydration due to cholera can result in death within hours, so the choice of antibiotic has to be made based on known prevalence of resistance among circulating strains (<link linkend="ch0061s000000li0108">108</link>). Clinical and Laboratory Standards Institute (CLSI) document M45 (3rd edition) (<link linkend="ch0061s000000li0109">109</link>) includes susceptibility testing guidelines for noncholera vibrios; CLSI interpretive guidelines are limited to ampicillin, tetracyclines, folate pathway inhibitors, and chloramphenicol for <emphasis>V. cholerae.</emphasis> An integrative genetic element designated the SXT element that carries genes encoding resistance to sulfamethoxazole, trimethoprim, chloramphenicol, and streptomycin emerged first in <emphasis>V. cholerae</emphasis> O139 strains in India and is now seen in O1, non-O1, and O139 cholera strains and <emphasis>V. fluvialis</emphasis> (<link linkend="ch0061s000000li0110">110</link>). Since 2005, most outbreak isolates of <emphasis>V. cholerae</emphasis> from Asia and Africa have been resistant to trimethoprim-sulfamethoxazole and nalidixic acid (<link linkend="ch0061s000000li0108">108</link>). Ahmed et al. (<link linkend="ch0061s000000li0110">110</link>) reported a <emphasis>V. fluvialis</emphasis> isolate with the SXT element and a novel aminoglycoside acetyltransferase gene encoding resistance to gentamicin; resistance to ampicillin, furazolidone, and nalidixic acid was also reported. Multidrug-resistant strains of <emphasis>V. fluvialis</emphasis> have also been noted among other strains from India (<link linkend="ch0061s000000li0057">57</link>). The non-<emphasis>V. cholerae</emphasis> vibrios generally do not show resistance to most antimicrobial agents except for ampicillin: 53% of <emphasis>Vibrio</emphasis> isolates and 97% of <emphasis>V. alginolyticus</emphasis> isolates monitored by the National Antimicrobial Resistance Monitoring System from 2014 to 2018 showed resistance to ampicillin (<link linkend="ch0061s000000li0111">111</link>). The fluoroquinolones alone or the synergistic combination of ciprofloxacin and cefotaxime shows excellent <emphasis>in vitro</emphasis> activity against <emphasis>V. vulnificus</emphasis> strains (<link linkend="ch0061s000000li0112">112</link>, <link linkend="ch0061s000000li0113">113</link>).</para>
        <anchor id="ch0061s000000a0071"/>
        <beginpage pagenum="864"/>
      </sect2>
      <sect2 id="ch0061s0020s0003">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0061s000020a0004"/>
        <anchor id="ch0061s000000a0072"/>
        <para id="ch0061s000000p0044">Isolation of<emphasis>V. cholerae</emphasis> O1 or O139 should be reported immediately to the health care provider because of the severe dehydration that cholera can produce. The case should also be phoned to public health authorities and the isolate sent to a public health laboratory for confirmation and toxin testing.</para>
        <para id="ch0061s000000p0045">When vibrios are isolated from blood or cerebrospinal fluid (bacteremia and meningitis are associated with high mortality rates) or wound infections, which cause extensive tissue damage (<emphasis>V. vulnificus</emphasis> and <emphasis>P. damselae</emphasis>), results should also be phoned immediately to the patient’s health care provider so that rapid and appropriate antibiotic therapy can be initiated. This is especially true for <emphasis>V. vulnificus</emphasis> infections, which have a high mortality rate without rapid, appropriate intervention. The clinical significance of <emphasis>Vibrio</emphasis> species (<emphasis>V. mimicus, V. alginolyticus, G. hollisae, V. harveyi</emphasis>, and <emphasis>V. metschnikovii</emphasis>) in other specimens, particularly stool, may be more difficult to determine and requires prompt consultation with the health care provider to better understand the clinical context. Most health care providers are not familiar with many <emphasis>Vibrionaceae</emphasis> species, and a phone consultation would be mutually beneficial to the laboratory and the patient’s direct health care provider. Information helpful to the health care provider includes the presence or absence of other pathogens and the relative amount of growth (pure or almost pure culture) of the <emphasis>Vibrio</emphasis> species. <emphasis>Vibrionaceae</emphasis> isolates should also be submitted to public health laboratories, because they are monitored under the CDC’s COVIS system; they may also be needed for subtyping.</para>
        <para id="ch0061s000000p0046"><emphasis>Vibrionaceae</emphasis> species that are known to cause diarrhea should be considered clinically significant, particularly if they are present in large numbers and no other potential pathogens are present. Isolation of vibrios from stool in small numbers may reflect only transitory colonization; however, species such as <emphasis>V. cholerae, V. mimicus</emphasis>, and <emphasis>V. parahaemolyticus</emphasis> have documented virulence factors that correlate with their ability to cause intestinal infections. Laboratory tests helpful in determining pathogenic potential are available primarily in reference laboratories. <emphasis>Vibrionaceae</emphasis> isolation from sites such as the ears may represent infection, transient colonization, or merely their presence after exposure to seawater. Again, isolation of <emphasis>Vibrionaceae</emphasis> requires prompt consultation with the patient’s health care provider to better understand the clinical context, which can help direct the need for further laboratory investigations.</para>
        <para id="ch0061s000000p0047">Finally, readers should be cautioned that misidentification of<emphasis>Vibrio</emphasis> species and their relatives can be a problem in the literature unless investigators used methods that are able to differentiate all of the species in the family <emphasis>Vibrionaceae</emphasis>.</para>
      </sect2>
      <sect2 id="ch0061s0020s0004">
        <title>REFERENCES</title>
        <anchor id="ch0061s000020a0005"/>
        <anchor id="ch0061s000000a0073"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0061s000000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Parte AC, Sardà Carbasse J, Meier-Kolthoff JP, Reimer LC, Göker M.</emphasis> 2020. List of Prokaryotic Names with Standing in Nomenclature (LPSN) moves to the DSMZ. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>5607–5612.</para>
          </listitem>
          <listitem id="ch0061s000000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Farmer J III, Janda JM, Brenner FW, Cameron DN, Birkhead KM.</emphasis> 2005. Genus I. Vibrio Pacini 1854, 411AL, p 494–546. <citetitle><emphasis>In</emphasis></citetitle> Brenner DJ, Krieg NR, Staley JT, Garrity G (ed), <citetitle><emphasis>The Proteobacteria, Part B. The Gammaproteobacteria</emphasis></citetitle>, 2nd ed, vol 2. Springer, New York, NY.</para>
          </listitem>
          <listitem id="ch0061s000000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">McCarter LL.</emphasis> 2001. Polar flagellar motility of the <citetitle><emphasis>Vibrionaceae. Microbiol Mol Biol Rev</emphasis></citetitle> <emphasis role="strong">65:</emphasis>445–462.</para>
          </listitem>
          <listitem id="ch0061s000000li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Islam MT, Nasreen T, Kirchberger PC, Liang KYH, Orata FD, Johura FT, Hussain NAS, Im MS, Tarr CL, Alam M, Boucher YF.</emphasis> 2021. Population analysis of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> in aquatic reservoirs reveals a novel sister species (<citetitle><emphasis>Vibrio paracholerae</emphasis></citetitle> sp. nov.) with a history of association with humans. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">87:</emphasis>e00422-21.</para>
          </listitem>
          <listitem id="ch0061s000000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Islam MT, Liang K, Orata FD, Im MS, Alam M, Lee CC, Boucher YF.</emphasis> 2022. <citetitle><emphasis>Vibrio tarriae</emphasis></citetitle> sp. nov., a novel member of the <citetitle><emphasis>Cholerae</emphasis></citetitle> clade. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <ulink url="https://doi.org/10.1099/ijsem.0.005571">https://doi.org/10.1099/ijsem.0.005571</ulink>.</para>
          </listitem>
          <listitem id="ch0061s000000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Kirchberger PC, Turnsek M, Hunt DE, Haley BJ, Colwell RR, Polz MF, Tarr CL, Boucher Y.</emphasis> 2014. <citetitle><emphasis>Vibrio metoecus</emphasis></citetitle> sp. nov., a close relative of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> isolated from coastal brackish ponds and clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">64:</emphasis>3208–3214.</para>
          </listitem>
          <listitem id="ch0061s000000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Nelson EJ, Harris JB, Morris JG Jr, Calderwood SB, Camilli A.</emphasis> 2009. Cholera transmission: the host, pathogen and bacteriophage dynamic. <citetitle><emphasis>Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>693–702.</para>
          </listitem>
          <listitem id="ch0061s000000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Thompson FL, Iida T, Swings J.</emphasis> 2004. Biodiversity of vibrios. <citetitle><emphasis>Microbiol Mol Biol Rev</emphasis></citetitle> <emphasis role="strong">68:</emphasis>403–431.</para>
          </listitem>
          <listitem id="ch0061s000000li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Binsztein N, Costagliola MC, Pichel M, Jurquiza V, Ramírez FC, Akselman R, Vacchino M, Huq A, Colwell R.</emphasis> 2004. Viable but nonculturable <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 in the aquatic environment of Argentina. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>7481–7486.</para>
          </listitem>
          <listitem id="ch0061s000000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Oliver JD.</emphasis> 2010. Recent findings on the viable but nonculturable state in pathogenic bacteria. <citetitle><emphasis>FEMS Microbiol Rev</emphasis></citetitle> <emphasis role="strong">34:</emphasis>415–425.</para>
          </listitem>
          <listitem id="ch0061s000000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Fakruddin M, Mannan KS, Andrews S.</emphasis> 2013. Viable but nonculturable bacteria: food safety and public health perspective. <citetitle><emphasis>ISRN Microbiol</emphasis></citetitle> <emphasis role="strong">2013:</emphasis>703813.</para>
          </listitem>
          <listitem id="ch0061s000000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Patel NM, Wong M, Little E, Ramos AX, Kolli G, Fox KM, Melvin J, Moore A, Manch R.</emphasis> 2009. <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> non-O1 infection in cirrhotics: case report and literature review. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">11:</emphasis>54–56.</para>
          </listitem>
          <listitem id="ch0061s000000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Jones MK, Oliver JD.</emphasis> 2009. <citetitle><emphasis>Vibrio vulnificus</emphasis></citetitle>: disease and pathogenesis. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">77:</emphasis>1723–1733.</para>
          </listitem>
          <listitem id="ch0061s000000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Orata FD, Xu Y, Gladney LM, Rishishwar L, Case RJ, Boucher Y, Jordan IK, Tarr CL.</emphasis> 2016. Characterization of clinical and environmental isolates of <citetitle><emphasis>Vibrio cidicii</emphasis></citetitle> sp. nov., a close relative of <citetitle><emphasis>Vibrio navarrensis. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>4148–4155.</para>
          </listitem>
          <listitem id="ch0061s000000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Paek J, Shin JH, Shin Y, Park I-S, Kim H, Kook J-K, Kang S-S, Kim D-S, Park K-H, Chang Y-H.</emphasis> 2017. <citetitle><emphasis>Vibrio injenensis</emphasis></citetitle> sp. nov., isolated from human clinical specimens. <citetitle><emphasis>Antonie van Leeuwenhoek</emphasis></citetitle> <emphasis role="strong">110:</emphasis>145–152.</para>
          </listitem>
          <listitem id="ch0061s000000li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Gladney LM, Katz LS, Knipe KM, Rowe LA, Conley AB, Rishishwar L, Mariño-Ramírez L, Jordan IK, Tarr CL.</emphasis> 2014. Genome sequences of <citetitle><emphasis>Vibrio navarrensis</emphasis></citetitle>, a potential human pathogen. <citetitle><emphasis>Genome Announc</emphasis></citetitle> <emphasis role="strong">2:</emphasis>e01188-14.</para>
          </listitem>
          <listitem id="ch0061s000000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Trinanes J, Martinez-Urtaza J.</emphasis> 2021. Future scenarios of risk of <citetitle><emphasis>Vibrio</emphasis></citetitle> infections in a warming planet: a global mapping study. <citetitle><emphasis>Lancet Planet Health</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e426–e435.</para>
          </listitem>
          <listitem id="ch0061s000000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Baker-Austin C, Trinanes J, Gonzalez-Escalona N, Martinez-Urtaza J.</emphasis> 2017. Non-cholera vibrios: the microbial barometer of climate change. <citetitle><emphasis>Trends Microbiol</emphasis></citetitle> <emphasis role="strong">25:</emphasis>76–84.</para>
          </listitem>
          <listitem id="ch0061s000000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Dutta D, Chowdhury G, Pazhani GP, Guin S, Dutta S, Ghosh S, Rajendran K, Nandy RK, Mukhopadhyay AK, Bhattacharya MK, Mitra U, Takeda Y, Nair GB, Ramamurthy T.</emphasis> 2013. <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>464–467.</para>
          </listitem>
          <listitem id="ch0061s000000li0020" role="bibliographyEntry">
            <anchor id="ch0061s000000a0074"/>
            <para>20.<emphasis role="strong">Faruque SM, Albert MJ, Mekalanos JJ.</emphasis> 1998. Epidemiology, genetics, and ecology of toxigenic <citetitle><emphasis>Vibrio cholerae. Microbiol Mol Biol Rev</emphasis></citetitle> <emphasis role="strong">62:</emphasis>1301–1314.</para>
          </listitem>
          <listitem id="ch0061s000000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">World Health Organization.</emphasis> 2021. International Coordinating Group (ICG) on Vaccine Provision for Cholera, Meningitis and Yellow Fever: report of the annual meeting, 23-24 September 2020, Geneva.</para>
          </listitem>
          <listitem id="ch0061s000000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">World Health Organization.</emphasis> 2017. <citetitle><emphasis>Weekly Epidemiological Record</emphasis></citetitle>, (Accessed 8 September 2017). <ulink url="https://urldefense.com/v3/__https:/apps.who.int/iris/bitstream/handle/10665/258910/WER9236.pdf?sequence=1&amp;isAllowed=y__;!!HYmSToo!ZdAFh1GLzJ2C5sudePkS_xAtcT2Y6qIq09u-zSCnHaM10PytBxaQhVWBT_VyctupudTTy3nnpeahuYVN11PcXg$https://apps.who.int/iris/bitstream/handle/10665/258910/WER9236.pdf?sequence=1&amp;isAllowed=y">https://urldefense.com/v3/__https:/apps.who.int/iris/bitstream/handle/10665/258910/WER9236.pdf?sequence=1&amp;isAllowed=y__;!!HYmSToo!ZdAFh1GLzJ2C5sudePkS_xAtcT2Y6qIq09u-zSCnHaM10PytBxaQhVWBT_VyctupudTTy3nnpeahuYVN11PcXg$https://apps.who.int/iris/bitstream/handle/10665/258910/WER9236.pdf?sequence=1&amp;isAllowed=y</ulink>.</para>
          </listitem>
          <listitem id="ch0061s000000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">World Health Organization.</emphasis> 2021. Cholera situation in Yemen. <ulink url="https://stacks.cdc.gov/view/cdc/42357">https://stacks.cdc.gov/view/cdc/42357</ulink>.</para>
          </listitem>
          <listitem id="ch0061s000000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">King AA, Ionides EL, Pascual M, Bouma MJ.</emphasis> 2008. Inapparent infections and cholera dynamics. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">454:</emphasis>877–880.</para>
          </listitem>
          <listitem id="ch0061s000000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Kaper JB, Morris JG Jr, Levine MM.</emphasis> 1995. Cholera. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">8:</emphasis>48–86.</para>
          </listitem>
          <listitem id="ch0061s000000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Safa A, Nair GB, Kong RY.</emphasis> 2010. Evolution of new variants of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1. <citetitle><emphasis>Trends Microbiol</emphasis></citetitle> <emphasis role="strong">18:</emphasis>46–54.</para>
          </listitem>
          <listitem id="ch0061s000000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Siddique AK, Nair GB, Alam M, Sack DA, Huq A, Nizam A, Longini IM Jr, Qadri F, Faruque SM, Colwell RR, Ahmed S, Iqbal A, Bhuiyan NA, Sack RB.</emphasis> 2010. El Tor cholera with severe disease: a new threat to Asia and beyond. <citetitle><emphasis>Epidemiol Infect</emphasis></citetitle> <emphasis role="strong">138:</emphasis>347–352.</para>
          </listitem>
          <listitem id="ch0061s000000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Nguyen BM, Lee JH, Cuong NT, Choi SY, Hien NT, Anh DD, Lee HR, Ansaruzzaman M, Endtz HP, Chun J, Lopez AL, Czerkinsky C, Clemens JD, Kim DW.</emphasis> 2009. Cholera outbreaks caused by an altered <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>1568–1571.</para>
          </listitem>
          <listitem id="ch0061s000000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Albert MJ, Nair GB.</emphasis> 2005. <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O139 Bengal—10 years on. <citetitle><emphasis>Rev Med Microbiol</emphasis></citetitle> <emphasis role="strong">16:</emphasis>135–143.</para>
          </listitem>
          <listitem id="ch0061s000000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Faruque SM, Chowdhury N, Kamruzzaman M, Ahmad QS, Faruque AS, Salam MA, Ramamurthy T, Nair GB, Weintraub A, Sack DA.</emphasis> 2003. Reemergence of epidemic <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O139, Bangladesh. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">9:</emphasis>1116–1122.</para>
          </listitem>
          <listitem id="ch0061s000000li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Zhang P, Zhou H, Diao B, Li F, Du P, Li J, Kan B, Morris JG Jr, Wang D.</emphasis> 2014. A molecular surveillance reveals the prevalence of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O139 isolates in China from 1993 to 2012. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1146–1152.</para>
          </listitem>
          <listitem id="ch0061s000000li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Chowdhury F, Mather AE, Begum YA, Asaduzzaman M, Baby N, Sharmin S, Biswas R, Uddin MI, LaRocque RC, Harris JB, Calderwood SB, Ryan ET, Clemens JD, Thomson NR, Qadri F.</emphasis> 2015. <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> serogroup O139: isolation from cholera patients and asymptomatic household family members in Bangladesh between 2013 and 2014. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">9</emphasis><emphasis role="strong">:</emphasis>e0004183.</para>
          </listitem>
          <listitem id="ch0061s000000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Crump JA, Bopp CA, Greene KD, Kubota KA, Middendorf RL, Wells JG, Mintz ED.</emphasis> 2003. Toxigenic <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">187:</emphasis>866–868.</para>
          </listitem>
          <listitem id="ch0061s000000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Tobin-D’Angelo M, Smith AR, Bulens SN, Thomas S, Hodel M, Izumiya H, Arakawa E, Morita M, Watanabe H, Marin C, Parsons MB, Greene K, Cooper K, Haydel D, Bopp C, Yu P, Mintz E.</emphasis> 2008. Severe diarrhea caused by cholera toxin-producing <citetitle><emphasis>vibrio cholerae</emphasis></citetitle> serogroup O75 infections acquired in the southeastern United States. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">47:</emphasis>1035–1040.</para>
          </listitem>
          <listitem id="ch0061s000000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Onifade TJ, Hutchinson R, Van Zile K, Bodager D, Baker R, Blackmore C.</emphasis> 2011. Toxin producing <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O75 outbreak, United States, March to April 2011. <citetitle><emphasis>Euro Surveill</emphasis></citetitle> <emphasis role="strong">16:</emphasis>19870.</para>
          </listitem>
          <listitem id="ch0061s000000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Abernethy P, WS.</emphasis> 2021. Climate change and <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> in herring eggs: the role of indigenous communities in public health outbreak responses. <citetitle><emphasis>Int J Indig Health</emphasis></citetitle> <emphasis role="strong">16:</emphasis>13–35.</para>
          </listitem>
          <listitem id="ch0061s000000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Arnett MV, Fraser SL, McFadden PE.</emphasis> 2008. Non-O1 <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> epidural brain infection in a 12-year-old boy after a depressed skull fracture. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">27:</emphasis>284–285.</para>
          </listitem>
          <listitem id="ch0061s000000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Ko WC, Chuang YC, Huang GC, Hsu SY.</emphasis> 1998. Infections due to non-O1 <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> in southern Taiwan: predominance in cirrhotic patients. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>774–780.</para>
          </listitem>
          <listitem id="ch0061s000000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Morris JGJ, Nair GB.</emphasis> 2002. “Non-cholera” <citetitle><emphasis>Vibrio</emphasis></citetitle> infections, p 557–571. <citetitle><emphasis>In</emphasis></citetitle> Blaser MJ, Smith PD, Greenberg HB, Ravdin JI, Guerrant RL (ed), <citetitle><emphasis>Infections of the Gastrointestinal Tract</emphasis></citetitle>, 2nd ed. Lippincott Williams and Wilkins, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0061s000000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Chitov T, Kirikaew P, Yungyune P, Ruengprapan N, Sontikun K.</emphasis> 2009. An incidence of large foodborne outbreak associated with <citetitle><emphasis>Vibrio mimicus. Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">28:</emphasis>421–424.</para>
          </listitem>
          <listitem id="ch0061s000000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Kay MK, Cartwright EJ, Maceachern D, McCullough J, Barzilay E, Mintz E, Duchin JS, Macdonald K, Turnsek M, Tarr C, Talkington D, Newton A, Marfin AA.</emphasis> 2012. <citetitle><emphasis>Vibrio mimicus</emphasis></citetitle> infection associated with crayfish consumption, Spokane, Washington, 2010. <citetitle><emphasis>J Food Prot</emphasis></citetitle> <emphasis role="strong">75:</emphasis>762–764.</para>
          </listitem>
          <listitem id="ch0061s000000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Su YC, Liu C.</emphasis> 2007. <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle>: a concern of seafood safety. <citetitle><emphasis>Food Microbiol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>549–558.</para>
          </listitem>
          <listitem id="ch0061s000000li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Centers for Disease Control and Prevention.</emphasis> 2014. <citetitle><emphasis>Summary of Human Vibrio Cases Reported to CDC, 2014.</emphasis></citetitle> Centers for Disease Control and Prevention, Atlanta, GA.</para>
          </listitem>
          <listitem id="ch0061s000000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">McLaughlin JB, DePaola A, Bopp CA, Martinek KA, Napolilli NP, Allison CG, Murray SL, Thompson EC, Bird MM, Middaugh JP.</emphasis> 2005. Outbreak of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> gastroenteritis associated with Alaskan oysters. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">353:</emphasis>1463–1470.</para>
          </listitem>
          <listitem id="ch0061s000000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Nair GB, Ramamurthy T, Bhattacharya SK, Dutta B, Takeda Y, Sack DA.</emphasis> 2007. Global dissemination of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> serotype O3:K6 and its serovariants. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">20:</emphasis>39–48.</para>
          </listitem>
          <listitem id="ch0061s000000li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Horseman MA, Surani S.</emphasis> 2011. A comprehensive review of <citetitle><emphasis>Vibrio vulnificus</emphasis></citetitle>: an important cause of severe sepsis and skin and soft-tissue infection. <citetitle><emphasis>Int J Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>e157–e166.</para>
          </listitem>
          <listitem id="ch0061s000000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Reilly GD, Reilly CA, Smith EG, Baker-Austin C.</emphasis> 2011. <citetitle><emphasis>Vibrio alginolyticus</emphasis></citetitle>-associated wound infection acquired in British waters, Guernsey, July 2011. <citetitle><emphasis>Euro Surveill</emphasis></citetitle> <emphasis role="strong">16:</emphasis>19994.</para>
          </listitem>
          <listitem id="ch0061s000000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Chien JY, Shih JT, Hsueh PR, Yang PC, Luh KT.</emphasis> 2002. <citetitle><emphasis>Vibrio alginolyticus</emphasis></citetitle> as the cause of pleural empyema and bacteremia in an immunocompromised patient. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>401–403.</para>
          </listitem>
          <listitem id="ch0061s000000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Lee DY, Moon SY, Lee SO, Yang HY, Lee HJ, Lee MS.</emphasis> 2008. Septic shock due to <citetitle><emphasis>Vibrio alginolyticus</emphasis></citetitle> in a cirrhotic patient: the first case in Korea. <citetitle><emphasis>Yonsei Med J</emphasis></citetitle> <emphasis role="strong">49:</emphasis>329–332.</para>
          </listitem>
          <listitem id="ch0061s000000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Uh Y, Park JS, Hwang GY, Jang IH, Yoon KJ, Park HC, Hwang SO.</emphasis> 2001. <citetitle><emphasis>Vibrio alginolyticus</emphasis></citetitle> acute gastroenteritis: report of two cases. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">7:</emphasis>104–106.</para>
          </listitem>
          <listitem id="ch0061s000000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Yamane K, Asato J, Kawade N, Takahashi H, Kimura B, Arakawa Y.</emphasis> 2004. Two cases of fatal necrotizing fasciitis caused by <citetitle><emphasis>Photobacterium damsela</emphasis></citetitle> in Japan. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>1370–1372.</para>
          </listitem>
          <listitem id="ch0061s000000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Goodell KH, Jordan MR, Graham R, Cassidy C, Nasraway SA.</emphasis> 2004. Rapidly advancing necrotizing fasciitis caused by <citetitle><emphasis>Photobacterium</emphasis></citetitle> (<citetitle><emphasis>Vibrio</emphasis></citetitle>) <citetitle><emphasis>damsela</emphasis></citetitle>: a hyperaggressive variant. <citetitle><emphasis>Crit Care Med</emphasis></citetitle> <emphasis role="strong">32:</emphasis>278–281.</para>
          </listitem>
          <listitem id="ch0061s000000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Nakamura Y, Uchihira M, Ichimiya M, Morita K, Muto M.</emphasis> 2008. Necrotizing fasciitis of the leg due to <citetitle><emphasis>Photobacterium damsela. J Dermatol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>44–45.</para>
          </listitem>
          <listitem id="ch0061s000000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Aigbivbalu L, Maraqa N.</emphasis> 2009. <citetitle><emphasis>Photobacterium damsela</emphasis></citetitle> wound infection in a 14-year-old surfer. <citetitle><emphasis>South Med J</emphasis></citetitle> <emphasis role="strong">102:</emphasis>425–426.</para>
          </listitem>
          <listitem id="ch0061s000000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Alvarez JR, Lamba S, Dyer KY, Apuzzio JJ.</emphasis> 2006. An unusual case of urinary tract infection in a pregnant woman with <citetitle><emphasis>Photobacterium damsela. Infect Dis Obstet Gynecol</emphasis></citetitle> <emphasis role="strong">2006:</emphasis>80682.</para>
          </listitem>
          <listitem id="ch0061s000000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Lai CH, Hwang CK, Chin C, Lin HH, Wong WW, Liu CY.</emphasis> 2006. Severe watery diarrhoea and bacteraemia caused by <citetitle><emphasis>Vibrio fluvialis. J Infect</emphasis></citetitle> <emphasis role="strong">52:</emphasis>e95–e98.</para>
          </listitem>
          <listitem id="ch0061s000000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Chowdhury G, Pazhani GP, Dutta D, Guin S, Dutta S, Ghosh S, Izumiya H, Asakura M, Yamasaki S, Takeda Y, Arakawa E, Watanabe H, Mukhopadhyay AK, Bhattacharya MK, Rajendran K, Nair GB, Ramamurthy T.</emphasis> 2012. <citetitle><emphasis>Vibrio fluvialis</emphasis></citetitle> in patients with diarrhea, Kolkata, India. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">18:</emphasis>1868–1871.</para>
          </listitem>
          <listitem id="ch0061s000000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Huang KC, Hsu RW.</emphasis> 2005. <citetitle><emphasis>Vibrio fluvialis</emphasis></citetitle> hemorrhagic cellulitis and cerebritis. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">40:</emphasis>e75–e77.</para>
          </listitem>
          <listitem id="ch0061s000000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Lee JY, Park JS, Oh SH, Kim HR, Lee JN, Shin JH.</emphasis> 2008. Acute infectious peritonitis caused by <citetitle><emphasis>Vibrio fluvialis. Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">62:</emphasis>216–218.</para>
          </listitem>
          <listitem id="ch0061s000000li0060" role="bibliographyEntry">
            <anchor id="ch0061s000000a0075"/>
            <para>60.<emphasis role="strong">Dalsgaard A, Glerup P, Høybye LL, Paarup AM, Meza R, Bernal M, Shimada T, Taylor DN.</emphasis> 1997. <citetitle><emphasis>Vibrio furnissii</emphasis></citetitle> isolated from humans in Peru: a possible human pathogen? <citetitle><emphasis>Epidemiol Infect</emphasis></citetitle> <emphasis role="strong">119:</emphasis>143–149.</para>
          </listitem>
          <listitem id="ch0061s000000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Derber C, Coudron P, Tarr C, Gladney L, Turnsek M, Shankaran S, Wong E.</emphasis> 2011. <citetitle><emphasis>Vibrio furnissii</emphasis></citetitle>: an unusual cause of bacteremia and skin lesions after ingestion of seafood. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>2348–2349.</para>
          </listitem>
          <listitem id="ch0061s000000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Hundenborn J, Thurig S, Kommerell M, Haag H, Nolte O.</emphasis> 2013. Severe wound infection with <citetitle><emphasis>Photobacterium damselae</emphasis></citetitle> spp. damselae and <citetitle><emphasis>Vibrio harveyi</emphasis></citetitle>, following a laceration injury in marine environment: a case report and review of the literature. <citetitle><emphasis>Case Rep Med</emphasis></citetitle> <emphasis role="strong">2013</emphasis>:610632.</para>
          </listitem>
          <listitem id="ch0061s000000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Del Gigia-Aguirre L, Sánchez-Yebra-Romera W, García-Muñoz S, Rodríguez-Maresca M.</emphasis> 2017. First description of wound infection with <citetitle><emphasis>Vibrio harveyi</emphasis></citetitle> in Spain. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">19:</emphasis>15–16.</para>
          </listitem>
          <listitem id="ch0061s000000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Tarr CL, Patel JS, Puhr ND, Sowers EG, Bopp CA, Strockbine NA.</emphasis> 2007. Identification of <citetitle><emphasis>Vibrio</emphasis></citetitle> isolates by a multiplex PCR assay and rpoB sequence determination. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>134–140.</para>
          </listitem>
          <listitem id="ch0061s000000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Hinestrosa F, Madeira RG, Bourbeau PP.</emphasis> 2007. Severe gastroenteritis and hypovolemic shock caused by <citetitle><emphasis>Grimontia</emphasis></citetitle> (<citetitle><emphasis>Vibrio</emphasis></citetitle>) <citetitle><emphasis>hollisae</emphasis></citetitle> infection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>3462–3463.</para>
          </listitem>
          <listitem id="ch0061s000000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Wallet F, Tachon M, Nseir S, Courcol RJ, Roussel-Delvallez M.</emphasis> 2005. <citetitle><emphasis>Vibrio metschnikovii</emphasis></citetitle> pneumonia. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">11:</emphasis>1641–1642.</para>
          </listitem>
          <listitem id="ch0061s000000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Linde HJ, Kobuch R, Jayasinghe S, Reischl U, Lehn N, Kaulfuss S, Beutin L.</emphasis> 2004. <citetitle><emphasis>Vibrio metschnikovii</emphasis></citetitle>, a rare cause of wound infection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>4909–4911.</para>
          </listitem>
          <listitem id="ch0061s000000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Wuthe HH, Aleksić S, Hein W.</emphasis> 1993. Contribution to some phenotypical characteristics of <citetitle><emphasis>Vibrio cincinnatiensis</emphasis></citetitle>. Studies in one strain of a diarrhoeic human patient and in two isolates from aborted bovine fetuses. <citetitle><emphasis>Zentralbl Bakteriol</emphasis></citetitle> <emphasis role="strong">279:</emphasis>458–465.</para>
          </listitem>
          <listitem id="ch0061s000000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Urdaci MC, Marchand M, Ageron E, Arcos JM, Sesma B, Grimont PA.</emphasis> 1991. <citetitle><emphasis>Vibrio navarrensis</emphasis></citetitle> sp. nov., a species from sewage. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>290–294.</para>
          </listitem>
          <listitem id="ch0061s000000li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Thompson FL, Gevers D, Thompson CC, Dawyndt P, Naser S, Hoste B, Munn CB, Swings J.</emphasis> 2005. Phylogeny and molecular identification of vibrios on the basis of multilocus sequence analysis. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>5107–5115.</para>
          </listitem>
          <listitem id="ch0061s000000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Gladney LM, Tarr CL.</emphasis> 2014. Molecular and phenotypic characterization of <citetitle><emphasis>Vibrio navarrensis</emphasis></citetitle> isolates associated with human illness. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>4070–4074.</para>
          </listitem>
          <listitem id="ch0061s000000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Marano NN, Daniels NA, Easton AN, McShan A, Ray B, Wells JG, Griffin PM, Angulo FJ.</emphasis> 2000. A survey of stool culturing practices for <citetitle><emphasis>Vibrio</emphasis></citetitle> species at clinical laboratories in Gulf Coast states. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>2267–2270.</para>
          </listitem>
          <listitem id="ch0061s000000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">World Health Organization.</emphasis> 2003. Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world. <ulink url="https://apps.who.int/iris/handle/10665/68554">https://apps.who.int/iris/handle/10665/68554</ulink>.</para>
          </listitem>
          <listitem id="ch0061s000000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Keddy KH, Sooka A, Parsons MB, Njanpop-Lafourcade BM, Fitchet K, Smith AM.</emphasis> 2013. Diagnosis of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 infection in Africa. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">208</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>S23–S31.</para>
          </listitem>
          <listitem id="ch0061s000000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Mwaba J, Ferreras E, Chizema-Kawesa E, Mwimbe D, Tafirenyika F, Rauzier J, Blake A, Rakesh A, Poncin M, Stoitsova S, Kwenda G, Azman AS, Chewe O, Serafini M, Lukwesa-Musyani C, Cohuet S, Quilici ML, Luquero FJ, Page AL.</emphasis> 2018. Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, Zambia. <citetitle><emphasis>Trop Med Int Health</emphasis></citetitle> <emphasis role="strong">23:</emphasis>834–840.</para>
          </listitem>
          <listitem id="ch0061s000000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Hoshino K, Yamasaki S, Mukhopadhyay AK, Chakraborty S, Basu A, Bhattacharya SK, Nair GB, Shimada T, Takeda Y.</emphasis> 1998. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 and O139. <citetitle><emphasis>FEMS Immunol Med Microbiol</emphasis></citetitle> <emphasis role="strong">20:</emphasis>201–207.</para>
          </listitem>
          <listitem id="ch0061s000000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Khuntia HK, Pal BB, Chhotray GP.</emphasis> 2008. Quadruplex PCR for simultaneous detection of serotype, biotype, toxigenic potential, and central regulating factor of <citetitle><emphasis>Vibrio cholerae. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>2399–2401.</para>
          </listitem>
          <listitem id="ch0061s000000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Bhoopong P, Palittapongarnpim P, Pomwised R, Kiatkittipong A, Kamruzzaman M, Nakaguchi Y, Nishibuchi M, Ishibashi M, Vuddhakul V.</emphasis> 2007. Variability of properties of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> strains isolated from individual patients. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1544–1550.</para>
          </listitem>
          <listitem id="ch0061s000000li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Serichantalergs O, Bhuiyan NA, Nair GB, Chivaratanond O, Srijan A, Bodhidatta L, Anuras S, Mason CJ.</emphasis> 2007. The dominance of pandemic serovars of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> in expatriates and sporadic cases of diarrhoea in Thailand, and a new emergent serovar (O3 : K46) with pandemic traits. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>608–613.</para>
          </listitem>
          <listitem id="ch0061s000000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Dien Bard J, McElvania E.</emphasis> 2020. Panels and syndromic testing in clinical microbiology. <citetitle><emphasis>Clin Lab Med</emphasis></citetitle> <emphasis role="strong">40:</emphasis>393–420.</para>
          </listitem>
          <listitem id="ch0061s000000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Binnicker MJ.</emphasis> 2015. Multiplex molecular panels for diagnosis of gastrointestinal infection: performance, result interpretation, and cost-effectiveness. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>3723–3728.</para>
          </listitem>
          <listitem id="ch0061s000000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Hitchcock MM, Hogan CA, Budvytiene I, Banaei N.</emphasis> 2019. Reproducibility of positive results for rare pathogens on the FilmArray GI panel. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">95:</emphasis>10–14.</para>
          </listitem>
          <listitem id="ch0061s000000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Decuir M, Fowler RC, Cebelinski E, Smith K, Boxrud D, Medus C.</emphasis> 2021. Evidence of false positivity for <citetitle><emphasis>Vibrio</emphasis></citetitle> species tested by gastrointestinal multiplex PCR panels, Minnesota, 2016-2018. <citetitle><emphasis>Open Forum Infect Dis</emphasis></citetitle> <emphasis role="strong">8:</emphasis>b247.</para>
          </listitem>
          <listitem id="ch0061s000000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Hara-Kudo Y, Nishina T, Nakagawa H, Konuma H, Hasegawa J, Kumagai S.</emphasis> 2001. Improved method for detection of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> in seafood. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>5819–5823.</para>
          </listitem>
          <listitem id="ch0061s000000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Ali A, Morris JG Jr, Johnson JA.</emphasis> 2005. Sugars inhibit expression of the rugose phenotype of <citetitle><emphasis>Vibrio cholerae. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>1426–1429.</para>
          </listitem>
          <listitem id="ch0061s000000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Yildiz FH, Schoolnik GK.</emphasis> 1999. <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">96:</emphasis>4028–4033.</para>
          </listitem>
          <listitem id="ch0061s000000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">O’Hara CM, Sowers EG, Bopp CA, Duda SB, Strockbine NA.</emphasis> 2003. Accuracy of six commercially available systems for identification of members of the family <citetitle><emphasis>Vibrionaceae. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>5654–5659.</para>
          </listitem>
          <listitem id="ch0061s000000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Croci L, Suffredini E, Cozzi L, Toti L, Ottaviani D, Pruzzo C, Serratore P, Fischetti R, Goffredo E, Loffredo G, Mioni R, Vibrio parahaemolyticus Working Group.</emphasis> 2007. Comparison of different biochemical and molecular methods for the identification of <citetitle><emphasis>Vibrio parahaemolyticus. J Appl Microbiol</emphasis></citetitle> <emphasis role="strong">102:</emphasis>229–237.</para>
          </listitem>
          <listitem id="ch0061s000000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Sanjuán E, Fouz B, Oliver JD, Amaro C.</emphasis> 2009. Evaluation of genotypic and phenotypic methods to distinguish clinical from environmental <citetitle><emphasis>Vibrio vulnificus</emphasis></citetitle> strains. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">75:</emphasis>1604–1613.</para>
          </listitem>
          <listitem id="ch0061s000000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Moreno C, Romero J, Espejo RT.</emphasis> 2002. Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus <citetitle><emphasis>Vibrio. Microbiology (Reading)</emphasis></citetitle> <emphasis role="strong">148:</emphasis>1233–1239.</para>
          </listitem>
          <listitem id="ch0061s000000li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Thompson CC, Vicente ACP, Souza RC, Vasconcelos ATR, Vesth T, Alves N Jr, Ussery DW, Iida T, Thompson FL.</emphasis> 2009. Genomic taxonomy of vibrios. <citetitle><emphasis>BMC Evol Biol</emphasis></citetitle> <emphasis role="strong">9:</emphasis>258.</para>
          </listitem>
          <listitem id="ch0061s000000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Konstantinidis KT, Tiedje JM.</emphasis> 2005. Genomic insights that advance the species definition for prokaryotes. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">102:</emphasis>2567–2572.</para>
          </listitem>
          <listitem id="ch0061s000000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Meier-Kolthoff JP, Auch AF, Klenk HP, Göker M.</emphasis> 2013. Genome sequence-based species delimitation with confidence intervals and improved distance functions. <citetitle><emphasis>BMC Bioinformatics</emphasis></citetitle> <emphasis role="strong">14:</emphasis>60.</para>
          </listitem>
          <listitem id="ch0061s000000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Besser J, Carleton HA, Gerner-Smidt P, Lindsey RL, Trees E.</emphasis> 2017. Next-generation sequencing technologies and their application to the study and control of bacterial infections. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">24:</emphasis>335–341. 10.1016/j.cmi.2017.10.013.</para>
          </listitem>
          <listitem id="ch0061s000000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Dieckmann R, Strauch E, Alter T.</emphasis> 2010. Rapid identification and characterization of <citetitle><emphasis>Vibrio</emphasis></citetitle> species using whole-cell MALDI-TOF mass spectrometry. <citetitle><emphasis>J Appl Microbiol</emphasis></citetitle> <emphasis role="strong">109:</emphasis>199–211.</para>
          </listitem>
          <listitem id="ch0061s000000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Manji R, Bythrow M, Branda JA, Burnham CAD, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC.</emphasis> 2014. Multi-center evaluation of the Vitek<superscript>®</superscript> MS system for mass spectrometric identification of non-<citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> Gram-negative bacilli. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">33:</emphasis>337–346.</para>
          </listitem>
          <listitem id="ch0061s000000li0097" role="bibliographyEntry">
            <anchor id="ch0061s000000a0076"/>
            <para>97.<emphasis role="strong">DePaola A, Ulaszek J, Kaysner CA, Tenge BJ, Nordstrom JL, Wells J, Puhr N, Gendel SM.</emphasis> 2003. Molecular, serological, and virulence characteristics of <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle> isolated from environmental, food, and clinical sources in North America and Asia. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">69:</emphasis>3999–4005.</para>
          </listitem>
          <listitem id="ch0061s000000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Cooper KL, Luey CK, Bird M, Terajima J, Nair GB, Kam KM, Arakawa E, Safa A, Cheung DT, Law CP, Watanabe H, Kubota K, Swaminathan B, Ribot EM.</emphasis> 2006. Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of <citetitle><emphasis>Vibrio cholerae. Foodborne Pathog Dis</emphasis></citetitle> <emphasis role="strong">3:</emphasis>51–58.</para>
          </listitem>
          <listitem id="ch0061s000000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Kam KM, Luey CK, Parsons MB, Cooper KL, Nair GB, Alam M, Islam MA, Cheung DT, Chu YW, Ramamurthy T, Pazhani GP, Bhattacharya SK, Watanabe H, Terajima J, Arakawa E, Ratchtrachenchai OA, Huttayananont S, Ribot EM, Gerner-Smidt P, Swaminathan B, Vibrio parahaemolyticus PulseNet PFGE Protocol Working Group.</emphasis> 2008. Evaluation and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping <citetitle><emphasis>Vibrio parahaemolyticus</emphasis></citetitle>: an international multicenter collaborative study. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>2766–2773.</para>
          </listitem>
          <listitem id="ch0061s000000li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Reynaud Y, Pitchford S, De Decker S, Wikfors GH, Brown CL.</emphasis> 2013. Molecular typing of environmental and clinical strains of <citetitle><emphasis>Vibrio vulnificus</emphasis></citetitle> isolated in the northeastern USA. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e83357.</para>
          </listitem>
          <listitem id="ch0061s000000li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Gonzalez-Escalona N, Jolley KA, Reed E, Martinez-Urtaza J.</emphasis> 2017. Defining a core genome multilocus sequence typing scheme for the global epidemiology of <citetitle><emphasis>Vibrio parahaemolyticus. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1682–1697.</para>
          </listitem>
          <listitem id="ch0061s000000li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Liang KYH, Orata FD, Islam MT, Nasreen T, Alam M, Tarr CL, Boucher YF, Brun YV.</emphasis> 2020. A <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> core genome multilocus ssequence typing scheme to facilitate the epidemiological study of cholera. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">202:</emphasis>e00086-20.</para>
          </listitem>
          <listitem id="ch0061s000000li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J, Fawal N, Keddy KH, Salje H, Moore S, Mukhopadhyay AK, Bercion R, Luquero FJ, Ngandjio A, Dosso M, Monakhova E, Garin B, Bouchier C, Pazzani C, Mutreja A, Grunow R, Sidikou F, Bonte L, Breurec S, Damian M, Njanpop-Lafourcade BM, Sapriel G, Page AL, Hamze M, Henkens M, Chowdhury G, Mengel M, Koeck JL, Fournier JM, Dougan G, Grimont PAD, Parkhill J, Holt KE, Piarroux R, Ramamurthy T, Quilici ML, Thomson NR.</emphasis> 2017. Genomic history of the seventh pandemic of cholera in Africa. <citetitle><emphasis>Science</emphasis></citetitle> <emphasis role="strong">358:</emphasis>785–789.</para>
          </listitem>
          <listitem id="ch0061s000000li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Frerichs RR, Keim PS, Barrais R, Piarroux R.</emphasis> 2012. Nepalese origin of cholera epidemic in Haiti. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">18:</emphasis>E158–E163.</para>
          </listitem>
          <listitem id="ch0061s000000li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Katz LS, Petkau A, Beaulaurier J, Tyler S, Antonova ES, Turnsek MA, Guo Y, Wang S, Paxinos EE, Orata F, Gladney LM, Stroika S, Folster JP, Rowe L, Freeman MM, Knox N, Frace M, Boncy J, Graham M, Hammer BK, Boucher Y, Bashir A, Hanage WP, Van Domselaar G, Tarr CL.</emphasis> 2013. Evolutionary dynamics of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> O1 following a single-source introduction to Haiti. <citetitle><emphasis>mBio</emphasis></citetitle> <emphasis role="strong">4:</emphasis>e00398-13.</para>
          </listitem>
          <listitem id="ch0061s000000li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Weill F-X, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici M-L.</emphasis> 2019. Genomic insights into the 2016-2017 cholera epidemic in Yemen. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">565:</emphasis>230–233.</para>
          </listitem>
          <listitem id="ch0061s000000li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Losonsky GA, Levine MM.</emphasis> 1997. Immunologic methods for diagnosis of infections caused by diarrheagenic members of the families <citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> and <citetitle><emphasis>Vibrionaceae. In</emphasis></citetitle> Balows A, Hausler W, Jr, Herrmann KL, Isenberg HD, Shadomy HJ (ed), <citetitle><emphasis>Manual of Clinical Microbiology</emphasis></citetitle>, 5th ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0061s000000li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Bennish ML, Khan WA, Ahmed S.</emphasis> 2017. Antimicrobial resistance in Vibrio, p 969–990. <citetitle><emphasis>In</emphasis></citetitle> Mayers DL, Sobel JD, Ouellette M, Kaye KS, Marchaim D (ed), <citetitle><emphasis>Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects</emphasis></citetitle>, vol 2. Springer, Cham, Switzerland.</para>
          </listitem>
          <listitem id="ch0061s000000li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2016. <citetitle><emphasis>M45: Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Frequently Isolated or Fastidious Bacteria.</emphasis></citetitle> Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0061s000000li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Ahmed AM, Shinoda S, Shimamoto T.</emphasis> 2005. A variant type of <citetitle><emphasis>Vibrio cholerae</emphasis></citetitle> SXT element in a multidrug-resistant strain of <citetitle><emphasis>Vibrio fluvialis. FEMS Microbiol Lett</emphasis></citetitle> <emphasis role="strong">242:</emphasis>241–247.</para>
          </listitem>
          <listitem id="ch0061s000000li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Centers for Disease Control and Prevention.</emphasis> National Antimicrobial Resistance Monitoring System (NARMS) now: human data. <ulink url="https://www.cdc.gov/narmsnow">https://www.cdc.gov/narmsnow</ulink>. Accessed 7 May 2022.</para>
          </listitem>
          <listitem id="ch0061s000000li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Kim DM, Lym Y, Jang SJ, Han H, Kim YG, Chung CH, Hong SP.</emphasis> 2005. <citetitle><emphasis>In vitro</emphasis></citetitle> efficacy of the combination of ciprofloxacin and cefotaxime against <citetitle><emphasis>Vibrio vulnificus. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">49:</emphasis>3489–3491.</para>
          </listitem>
          <listitem id="ch0061s000000li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC.</emphasis> 2002. <citetitle><emphasis>In vitro</emphasis></citetitle> and <citetitle><emphasis>in vivo</emphasis></citetitle> activities of newer fluoroquinolones against <citetitle><emphasis>Vibrio vulnificus. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">46:</emphasis>3580–3584.</para>
          </listitem>
        </itemizedlist>
      </sect2>
    </sect1>
  </chapter>
